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Identiﬁcation informatique des relations entre les concepts médicaux et l’analyse par
grappes dans les notes cliniques
Ruth María REÁTEGUI ROJAS
RÉSUMÉ
Les textes cliniques contiennent des informations variées qui mettent en relief des concepts
médicaux ou des entités; on y trouve des formes de surface et des codes qui correspondent
entre autres à des maladies, des traitements et des médicaments. Ces dernières –les entités–
donnent au clinicien une impression générale et exhaustive de la santé du patient. L’analyse
automatique de cette information riche est pertinente pour les experts et les chercheurs de la
santé aﬁn d’identiﬁer des associations parmi les entités médicales. Cependant, l’extraction
automatique d’information à partir des textes cliniques constitue un déﬁ à cause de leur format
narratif et leur structure libre.
Cette recherche décrit un processus pour extraire de manière automatique des entités médicales
aﬁn d’identiﬁer des grappes de patients ainsi que les relations entre les maladies et les traite-
ments. L’ensemble de données i2b2 2008 Obesity a été utilisé. Cet ensemble de données est
composé de 1237 résumés sur le surpoids et les patients diabétiques, donc ce travail ﬁxe son
regard sur les maladies liées à l’obésité.
Pour l’extraction automatique des entités médicales, les outils MetaMap et cTAKES ont été
utilisés pour comparer leur capacité d’extraction automatique. Les modules du Uniﬁed Med-
ical Language System ont été mis à contribution pour ajouter des informations à propos des
entités extraites. Pour l’identiﬁcation des grappes de patients, deux approches sont proposées.
Premièrement, l’algorithme de groupement K-moyen disperses est appliqué sur une matrice
patient-maladie comportant 14 comorbidités liées à l’obésité. Deuxièmement, pour visualiser
et analyser d’autres maladies présentes sur les données cliniques, 86 maladies ont été utilisées
pour former des grappes selon une approche fondée sur des graphes. Les graphiques bipartites
obtenus ont permis d’explorer les relations maladie-traitement corrélées avec les principales
grappes obtenues.
Le résultat des expérimentations a montré que cTAKES est préférable à MetaMap, mais que
cette situation peut changer si l’on modiﬁe les choix de conﬁguration des outils – les listes
d’abréviations par exemple. De surcroît, l’ajout de concepts (avec des types sémantiques
similaires ou différents) s’avère une bonne stratégie pour améliorer l’acquisition automatique
d’entités médicales à partir de textes cliniques.
L’algorithme K-moyen disperses a distingué trois types de grappes (élevée, moyenne et basse);
ces groupes ont été identiﬁés en fonction du nombre de comorbidités et du pourcentage de
patients affectés par elles. Ces résultats montrent que le diabète, l’hypercholestérolémie, la
maladie cardiovasculaire, l’insufﬁsance cardiaque congestive, l’apnée obstructive pendant le
sommeil, et la dépression sont les maladies les plus répandues.
VIII
La construction des graphes a permis de visualiser et d’analyser l’information des patients;
elle a permis l’identiﬁcation de trois sous-graphes: des patients obèses avec des problèmes de
métabolisme, des patients obèses avec problèmes infectieux, et des patients obèses avec des
problèmes mécaniques. Les graphes bipartites pour une relation maladie-traitement mettent
ainsi en relief les traitements pour différents types de maladie, les patients obèses souffrant de
multiples troubles de santé.
Cette thèse conﬁrme que les textes narratifs cliniques en forme libre constituent une source
d’information très riche qui peut être utilisée pour explorer, visualiser, et analyser l’information
des patients grâce à une méthode automatisée. D’autres travaux sont nécessaires pour explorer
la relation entre les différentes entités médicales des textes cliniques et les autres ensembles de
données médicales. L’aspect temporel des données devrait également être considéré dans de
futurs travaux aﬁn de former un portrait personnalisé des grappes, des maladies et des patients.
Mots-clés: analyse par grappes, approche basée sur les réseaux, k-moyennes disperses, don-
nées cliniques, obésité
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ABSTRACT
Clinical notes contain information about medical concepts or entities (such as diseases, treat-
ments and drugs) that provide a comprehensive and overall impression of the patient’s health.
The automatic extraction of these entities is relevant for health experts and researchers as they
identify associations between the latter. However, automatically extracting information from
clinical notes is challenging, due to their narrative format.
This research describes a process to automatically extract and aggregate medical entities from
clinical notes, as well as the process to identify clusters of patients and disease-treatment rela-
tionships. The i2b2 2008 Obesity dataset was used, and consists of 1237 discharge summaries
of overweight and diabetic patients. Therefore, this thesis is focused on obesity diseases.
For the automatic extraction of medical entities, MetaMap and cTAKES were used, and the
automatic extraction capacity of both tools compared. Also, UMLS enabled the aggregation
of the extracted entities. Two approaches were applied for cluster analysis. Firstly, a sparse
K-means algorithm was used over a patient-disease matrix with 14 comorbidities related to
obesity. Secondly, to visualize and analyze other diseases present in the clinical notes, 86
diseases were used to identify clusters of patients with a network-based approach. Further-
more, bipartite graphs were used to explore disease-treatment relationships among some of the
clusters obtained.
The result of the experiments we conducted show cTAKES slightly outperforming MetaMap,
but this situation can change, considering other conﬁguration options in the respective tools,
including an abbreviation list. Moreover, concept aggregation (with similar and different se-
mantic types) was shown to be a good strategy for improving medical entity extraction.
The sparse K-means enabled identiﬁcation of three types of clusters (high, medium and low),
based on the number of comorbidities and the percentage of patients suffering from them.
These results show that diabetes, hypercholesterolemia, atherosclerotic cardiovascular dis-
eases, congestive heart failure, obstructive sleep apnea, and depression were the most prevalent
diseases.
With the network approach, it was possible to visualize and analyze patient information. In
it, three sub-graphs or clusters were identiﬁed: obese patients with metabolic problems, obese
patients with infection problems, and obese patients with a mechanical problem. Bipartite
graphs for a disease-treatment relationship showed treatments for different types of diseases,
which means that obese patients are suffering from multiple diseases.
XThis work shows that clinical notes are a rich source of information, and they can be used to
explore, visualize, and analyze patient’s information by applying different approaches. More
work is needed to explore the relationship between the different medical entities from clini-
cal notes and from different disease datasets. Also, considering that some medical documents
express events in time, this characteristic should be considered in future works to form a per-
sonalized portrait of clusters, diseases and patients.
Keywords: cluster analysis, network-based approach, graph, sparse K-means, clinical notes,
obesity
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INTRODUCTION
Nowadays, most health institutions employ Electronic Medical Records (EMR) or Electronic
Health Records (EHR) with a large quantity of clinical data in a structured format (e.g., ICD
and SNOMED-CT codes) and unstructured or narrative format (e.g., discharge records, radiol-
ogy reports). The narrative format of clinical notes, such as in discharge summaries, provides a
comprehensive and overall impression of the patient’s health (Lyalina et al., 2013; Alnazzawi
et al., 2015). As an example, the symptoms expressed by patients in the course of their illness,
and recorded by health professionals, present more complete descriptions of a disease than the
diagnosis expressed by a code (Jackson et al., 2017).
Clinical notes contain medical concepts or entities, including diseases, treatments and drugs.
Health professionals and researchers are interested in extracting medical entities (Chiaramello
et al., 2016; Pradhan et al., 2015; Becker & Bockmann, 2016) from clinical notes as a means
to understand a patient’s characterization. Furthermore, medical entities form the basis for
other analytical tasks, such as cluster analysis and disease-treatment relationships identiﬁca-
tion. These tasks help improve the customized treatment or care delivery (Zhang et al., 2014),
deﬁne boundaries and classify diseases (Lyalina et al., 2013), predict the health of patients with
similar characteristics (Shivade et al., 2014), etc.
Many diseases can be analyzed by considering information from EHR, and more speciﬁcally,
from clinical notes, with, obesity being one of them. Overweight and obesity are becoming an
epidemic affecting much of the industrialized world, particularly minority groups (Aneja et al.,
2004; Laing et al., 2015; Kovesdy et al., 2017). These health problems are also accompanied
by comorbidities such as: hypertension, coronary heart disease, congestive heart failure, renal
diseases, diabetes, asthma, osteoarthritis, cancer, atherosclerosis and obstructive sleep apnea
(Aneja et al., 2004; Sutherland et al., 2012; Laing et al., 2015; LaGrotte et al., 2016; Guh
et al., 2009).
2Obesity has been studied for a long time, and this has led to the conclusion that obesity is
a risk factor for some diseases. However, some questions and discrepancies exist because
of the variety of obese patient proﬁles available. For example, few studies have examined
the prevalence of obesity in different stages of chronic kidney diseases (Evangelista et al.,
2018) or how obesity inﬂuences cardiovascular mortality (Laing et al., 2015). Moreover, many
studies have analyzed obesity in relationship with a few of its comorbidities instead of all the
comorbidities or conditions that can afﬂict an obese patient.
0.1 Problem statement
The narrative format of clinical notes is peculiar for many reasons. First, the notes contain
many abbreviations, acronyms, and misspellings (Chiaramello et al., 2016; Shivade et al.,
2014). Secondly, a variety of natural languages are used, depending on the particular health
professional or institution (Pereira et al., 2013). These characteristics complicate the extraction
of medical entities from a large number of notes or patients (Pradhan et al., 2015; Chiaramello
et al., 2016). Furthermore, entity extraction is a time-consuming, labor-intensive, and error-
prone endeavor (Shivade et al., 2014; Savova et al., 2010), when done automatically; and worse
when done manually.
The patient information contained in clinical notes is scattered and hidden in different parts
of the document, meaning that information can be in several sections, and in no particular
order. Moreover, the information may be present in different documents, such as discharge
summaries, laboratory results, and radiography summaries. All these problems make medical
entity extraction and analysis a challenging task. For such cases, the information must be
located and correctly interpreted (Alnazzawi et al., 2015).
Although tools like MetaMap and cTAKES have been widely used to extract medical entities
(Pradhan et al., 2015; Kovacevic et al., 2013), new ﬁndings could appear when they are used in
3clinical notes on speciﬁc diseases. In fact, (Pradhan et al., 2013) have shown that entity extrac-
tion performance varies with text source (e.g., different languages and types of documents).
Moreover, no study to date has compared both MetaMap and cTAKES. This comparison could
help identify the advantages and disadvantages of both tools and allow recommendations on
considerations to be made when selecting a tool for entity extraction. Furthermore, the use
of an existing tool is the best option when there is limited time and money for the process of
named entity extraction or named entity recognition.
Regarding the analysis of clinical information, and speciﬁcally cluster analysis, different dis-
eases have been studied, such as obstructive sleep apnea (Vavougios et al., 2016), asthma
(Serrano-Pariente et al., 2015), knee osteoarthritis (van der Esch et al., 2015), chronic heart
failure (Ahmad et al., 2014), etc. However, there is a need to analyze and explore new dis-
eases, and obesity is an important disease that deserves deep study.
Furthermore, clusters analysis studies on obesity collected the information manually or from
structured EHR data instead of clinical notes. This case must be related with the scarcity
of annotated EHR datasets, the sensitivity of the data, and the difﬁcult process of data de-
identiﬁcation (Alnazzawi et al., 2015). Moreover, notwithstanding the presence of multiple
comorbidities in obese patients, most works focus on analyzing the relationship between 2
comorbidities.
Various methods, strategies and tools have been applied for cluster analysis: statistical analysis
and hierarchical clustering methods are some examples. Other methods and approaches could
be applied to explore and analyze relationships between different medical entities. Moreover,
considering the need to visualize information either to identify relationships or patterns within
clinical documents, graph and network approaches can be exploited. In the biomedical domain,
these approaches have been used with large amounts of data to identify relationships such as
gene-disease, symptom-disease, and vaccine-gene (Pavlopoulos et al., 2018). Nevertheless,
4few works have applied these approaches with unstructured information for cluster analysis
and the disease-treatment relationships.
This thesis focuses on the extraction and analysis of information from clinical notes, with
obesity as the principal disease to explore. Hence, the research question is:
Can patients’ clinical notes provide new insights about a disease?
0.2 Objectives and contributions
Considering the above limitations, the general objective of this research is to analyze clinical
notes to extract hidden data and information related to obese patients. The speciﬁc objectives
are: 1) automatically extract medical entities, and 2) analyze the entities extracted in order to
a) identify clusters of patients, and b) identify graphs of patients and disease-treatment rela-
tionships.
To achieve the goal of this thesis, three main contributions were made:
1) Automatically extract medical entities from clinical notes. MetaMap and cTAKES have
been widely used to extract medical entities. Hence, these tools were used to automatically
extract medical entities from obese patient discharge summaries. Next, a comparison of both
tools and some important remarks are made. The results were published in the following paper:
Reátegui, R., & Ratté, S. (2018). Comparison of MetaMap and cTAKES for entity extraction in
clinical notes. BMC Medical Informatics Decision Making, 2018 (Suppl 3), 74. https://doi.org/10.1186/s12911-
018-0654-2
2) Identify clusters of patient based on medical entities extracted from clinical notes. Many
research works have been done to identify clusters of obesity, but most of them were focused
on structured information, such as ICD codes, or analyzed relationships between one or two
5obesity comorbidities. Therefore, a second contribution is an cluster analysis of obesity based
on obesity comorbidities extracted automatically from discharge summaries. The results were
published in the following paper:
Reátegui, R., Ratté, S., Bautista-Valarezo, E.& Duque, V. Cluster Analysis of Obesity Disease
Based on Comorbidities Extracted from Clinical Notes. Journal of Medical Systems, (2019)
43:52. https://doi.org/10.1007/s10916-019-1172-1
3) Analyze and visualize medical entity relationships using a network-based approach. Many
approaches, methods and techniques have been used to analyze relationships of medical enti-
ties. A network-based approach helps visualize and infer knowledge about medical entity rela-
tionships. Hence, this approach was used to identify clusters of patients and disease-treatment
relationships from obese patient discharge summaries. The results were published in the fol-
lowing paper:
Reátegui, R., Ratté, S., Bautista-Valarezo, E., & Beltrán, J.F. A network-based analysis of med-
ical information extracted from electronic medical records. International Journal of Medical
Informatics. (Under Review)
0.3 Synthesis of links between contributions
We mentioned earlier that the main interest of the present research is to analyze clinical notes
to extract hidden data and information related to a speciﬁc disease. In order to achieve this
goal, two steps are needed: 1) a medical entity extraction process, and 2) an analysis of the
entities extracted.
Therefore, our ﬁrst contribution aims to show that it is possible to automatically extract medical
entities from discharge summaries by comparing the result obtained with two tools, MetaMap
6and cTAKES. The entities extracted will be the features or variables used in the next contribu-
tion.
For the analysis of these extracted entities, we considered two two different approach: a) a
cluster analysis, and b) a network-based approach.
The second contribution proposes a cluster-based approach to identify clusters of obese pa-
tients; the approach is based on 14 features or obesity comorbidities obtained from the ﬁrst
contribution. The sparse K-means algorithm was applied to identify clusters and a set of fea-
tures that could explain the main characteristics of each group of patients.
In order, to explore relevant details about the obesity disease, supplementary features (86 dis-
eases and 257 treatments) were automatically extracted following the process described in the
ﬁrst contribution. Then, considering a network approach and the information about the dis-
eases, graphs of patients were found. These bipartite graphs allowed us to visualize association
between some diseases and treatments.
0.4 Structure of thesis
This thesis comprises ﬁve chapters, as follows.
Chapter 1 presents the main concepts and a review of works related to medical entity ex-
traction, patients clusters analysis, and disease-treatment relationships. A brief description of
the dataset used is also presented. Chapter 2 introduces medical entity extraction using two
existing tools, namely, MetaMap and cTAKES. This work was published in the journal BMC
Medical Informatics and Decision Making. Chapter 3 presents an cluster analysis of obesity
disease based on comorbidities using Sparse K-means. This work was published in the Journal
of Medical Systems. Chapter 4 presents a network-based approach to identify clusters of pa-
tients and disease-treatment relationship. This work was submitted to the International Journal
7of Medical Informatics. Chapter 5 presents a general discussion, the conclusion and some
perspectives for future research.

CHAPTER 1
LITERATURE REVIEW
To extract knowledge from clinical notes, two main steps are needed: ﬁrst, extract medical en-
tities that will become features or variables, and second, analyze the medical entities extracted.
Hence, this chapter is divided into two main sections: medical entity recognition and medical
entity analysis. This thesis has a special interest in clusters analysis of obese patients.
1.1 Named entity recognition
The problem of automatically extracting relevant concepts from text is known as named entity
recognition (NER) (Jonnalagadda et al., 2012). In the medical ﬁeld, NER refers to the process
of identifying medical entities or concepts such as a diseases, treatments, drugs, etc. Some
approaches, and a combination thereof, have been used for NER: a dictionary-based approach
uses a dictionary or lexicon of the concepts to be extracted; a rule-based approach identiﬁes
rules related to the entities to be extracted, while the machine learning approach uses algorithms
that require an annotated data training dataset.
Dictionary-based and rule-based approaches were the ﬁrst to be used for NER, and are still
being used in some investigations. In (Alnazzawi et al., 2015), a dictionary-based method us-
ing the MetaMap tool, a rule-based approach, and 3 machine learning methods (hidden Markov
models (HMMs), maximum entropy Markov models (MEMMs), and conditional random ﬁelds
(CRFs)) were evaluated to extract some medical entities from clinical notes and articles. The
result shows that rules had the highest F-score for both clinical notes and articles. Similarly,
(Jonnalagadda et al., 2017) used a rule-based system to identify terms, and consequently, pa-
tients with heart failure with preserved ejection fraction. The rules were applied on multiple
unstructured notes.
The most popular machine learning methods used to NER are CRFs and support vector ma-
chine (SVM). As an example, (Jonnalagadda et al., 2012) extracted medical problems, treat-
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ments and tests from clinical notes combining distributional semantics and machine learning
algorithms. They used a sliding window and Random Indexing for dimension reduction, after
which they worked with a CRF algorithm, adding distributional semantic features to lexicons
and linguistic features. The CRF model created during the training phase is used to tag the in-
put sentences with concepts such as medical problems, treatments and tests. In addition, (Tang
et al., 2013) worked on two tasks, namely, disorder entity recognition and encoding. For the
ﬁrst task, they used a machine learning approach, and for the second one, a vector space model.
In this work, the structural SVM algorithm outperformed CRF in disorder recognition.
Recently, deep learning methods have been applied to improve NER systems in the biomedical
and medical ﬁelds. (Zhu et al., 2018) implemented a convolutional neural network (CNN) with
character embedding and word embedding. They achieved a better performance as compared
to the conventional machine learning approach for Biomedical NER; however, their work has
some limitations, including the fact that it is not prepared to consider overlapping or disjointed
mentions or mentions in tables. Also, it requires a signiﬁcant amount of training data and is
time-consuming. Similarly, (Wu et al., 2017) analyzed CNN and the recurrent neural network
(RNN) to extract concepts from clinical texts. They compared both methods with three baseline
(CRFs) models and two state-of-the-art clinical NER systems. The results showed that RNN
achieved a superior performance for NER.
1.1.1 Limitation of NER approaches
All the above-mentioned approaches have greatly contributed to improving NER in all ﬁelds.
However, each of them presents some limitations or problems that must be considered before
they are selected for a given research work.
Due to the large amount of medical terminology and the continuous increase in vocabulary, the
size of a dictionary can become a problem in the performance of dictionary-based approaches
(Sun et al., 2018; Zhu et al., 2018). Moreover, as free text, clinical notes include a lot of
misspellings, abbreviations and synonyms not covered in the dictionary.
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Rules-based approaches raise some problems for consideration: (1) these methods require do-
main knowledge for manual examination and pattern extraction, which makes them costly and
time-consuming; (2) the methods are prone to errors, and scarcity of information in their data
can lead to inappropriate or unconsidered rules; (3) the rules identiﬁed are valid only for the
dataset analyzed, and are thus hard to extrapolate to other domains (Sun et al., 2018; Zhu et al.,
2018).
The main problem with a machine learning approach is that it requires labeled or annotated
datasets. The amount of labeled data and the features used by learning algorithms are time-
consuming and computationally intensive (Zhu et al., 2018).
As we can see, all the NER approaches present some problems and challenges for medical
entity extraction. The present work reviews two of the most commonly used NER tools, which
enable medical entity extraction without requiring too much time or necessitating expert inter-
vention. The next section introduces these tools.
1.1.2 Medical entity extraction tools
Currently, various tools exist for extracting information from clinical texts created in an un-
structured format. Two such tools, both widely known and used in the biomedical ﬁeld, are
MetaMap and cTAKES (Pradhan et al., 2015; Kovacevic et al., 2013).
MetaMap was developed by the National Library of Medicine (NLM) to map biomedical
text to concepts in the Uniﬁed Medical Language System (UMLS) (Aronso, 2001; Aron-
son & Lang, 2010). The tool uses a hybrid approach combining natural language process-
ing (NLP), a knowledge-intensive approach and computational linguistic techniques (Aronso,
2001). Metamap execute some tasks such as: tokenization, sentence boundary determination
and acronym/abbreviation identiﬁcation, part-of-speech (POS) tagging, lexical lookup of input
words in the SPECIALIST lexicon, shallow parse, variant generation, candidate identiﬁcation,
mapping construction and word sense disambiguation (WSD) (Aronson & Lang, 2010).
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Similarly, the Clinical Text Analysis and Knowledge Extraction System (cTAKES) combines
rule-based and machine learning techniques to extract information from a clinical text (Savova
et al., 2010). cTAKES executes some components in sequence to process the clinical text. Its
components include a sentence boundary detector, a tokenizer, a normalizer, a part-of-speech
tagger, a shallow parser, and NER with a status and negation annotator. The NER component
implements a dictionary lookup algorithm to map a named entity to a concept from the termi-
nology. Initially, a UMLS subset that includes SNOMED-CT and RxNORM vocabularies was
used (Savova et al., 2010), but today, it is possible to include other sources and even create
custom dictionaries.
Both tools use the Uniﬁed Medical Language System (UMLS) to extract and standardize med-
ical concepts. A brief explanation of UMLS is presented below.
1.1.3 Uniﬁed medical language system - UMLS
The Uniﬁed Medical Language System (UMLS) provides terminology, coding standards, and
resources for biomedical and electronic health systems. UMLS was developed by the National
Library of Medicine (NLM) in the United States. UMLS has three Knowledge Sources: the
Metathesaurus, the Semantic Network and the SPECIALIST Lexicon & Lexical Tools.
The Metathesaurus is organized by concepts or meanings. A concept has a unique and per-
manent identiﬁer (CUI) and a preferred name. The concept is a meaning, and a meaning can
have different names from different vocabularies or thesauruses (National Library of Medicine
(US), 2009). UMLS grabs the meanings of a concept from different sources and links all o
that are synonyms. As an example of UMLS coding, hypertension is represented with the CUI
"C0020538" and the preference name "hypertension diseases".
The Semantic Network provides (1) a categorization (semantic types) of all concepts repre-
sented in the UMLS Metathesaurus; and (2) a set of relationships (semantic relations) between
these concepts (National Library of Medicine (US), 2009). The Semantic Network contains
133 semantic types and 54 relationships.
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Some of the semantic types deﬁned by UMLS and of interest for this thesis are:
- Antibiotic (antb)
- Clinical drug (clnd)
- Disease or syndrome (dsyn)
- Mental or behavioral dysfunction (mobd)
- Neoplastic process (neop)
- Pathologic function (patf)
- Therapeutic or preventive procedure (topp)
- Pharmacologic substance (phsu)
The SPECIALIST Lexicon is a general English lexicon of biomedical terms. It contains syntac-
tic, morphological, and orthographic information. The Lexical Tools are programs for language
processing (National Library of Medicine (US), 2009).
UMLS is based on some electronic thesauruses, classiﬁcations, code sets, and controlled terms
list such as SNOMED CT and RxNorm (National Library of Medicine (US), 2009). The
Systematized Nomenclature of Medicine - Clinical Terms (SNOMED CT) is a multilingual
health terminology used for the electronic exchange of clinical health information. In the U.S.,
SNOMED CT is a international standard for electronic exchange of clinical health information
(National Library of Medicine (US), 2016). On the other hand, RxNorm standardizes clinical
drug names and links the names to other vocabularies used in pharmacy management and drug
interaction software (National Library of Medicine (US), 2014).
1.1.4 Evaluation metrics
The three metrics used to evaluate the result of a NER task are precision (P), recall (R) and
F-score.
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Precision=
TP
TP+FP
(1.1)
Recall =
TP
TP+FN
(1.2)
F− score= 2. Precision.Recall
Precision+Recall
(1.3)
where TP is the number of true positives, FN is the number of false negatives, and FP is the
number of false positives.
1.2 Medical entities analysis
Once the entities have been extracted, a variety of tasks can be developed. A task of interest in
this thesis is patients cluster analysis, and disease-treatment relationships identiﬁcation.
1.2.1 Patients cluster analysis
This thesis aims to explore clinical notes to identify clusters of patients with similar charac-
teristics or phenotypes through the association of comorbidities and to discover novel insights
about obesity-related diseases. Obesity is a heterogeneous disease, which makes it difﬁcult to
classify patients using predetermined criteria. Hence, this work aims to explore this disease
and the different conditions that can accompany it.
Cluster analysis based on patients medical information might help in personalized treatment
management, patient symptom control, boundary deﬁnition and disease taxonomies, under-
standing the heterogeneity of the disease, predicting the health of patients with similar char-
acteristics, predicting future patient risks, and identifying relevant pathophysiology (Bourdin
et al., 2014; Lyalina et al., 2013; Shivade et al., 2014; Zhang et al., 2014).
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Many studies have worked with cluster analysis. These studies are diverse in methodology
and diseases analyzed. As an example, (Joosten et al., 2012) applied K-means algorithms to
identify patient with obstructive sleep apnea. They analyzed patient data through a hospital
records system. The same disease was studied by (Vavougios et al., 2016), who carried out
a cluster analysis using two-step algorithms. Data was collected from 1472 patient records
recovered from the University of Larissa Sleep Laboratory database (ULDB). Furthermore,
(Bourdin et al., 2014) applied Ward’s minimum variance hierarchical clustering method to
identify groups of asthma patients. They worked with information from recruitment patients
with severe asthma. Also, (Serrano-Pariente et al., 2015) used two-step algorithms to identify
and characterize near-fatal ashtma phenotypes. They worked with 84 cases from the Multicen-
tric Life-Threatening Ashtma Study (MLTAS).
K-means was used by (van der Esch et al., 2015) to carry out a cluster analysis and identify and
validate established knee osteoarthritis phenotypes. These authors analyzed information on 551
patients from the Amsterdam OA (AMS-OA) cohort, with a unilateral or bilateral diagnosis of
knee OA. (Ahmad et al., 2014) used Ward’s minimum variance hierarchical clustering method
to identify clusters of patients with chronic heart failure. They used the information from
Heart Failure: A Controlled Trial Investigating Outcomes of Exercise Training (HF-ACTION
). (Chen et al., 2014) worked with Ward’s minimum variance hierarchical clustering method to
deﬁne phenotypes of males with chronic obstructive pulmonary diseases. The features studied
were obtained from 377 male recruits.
Furthermore, (Bukhanov et al., 2017) used frequency analysis, association rules mining, and
Bayesian network to identify groups of comorbidities in hypertensive patients. Information was
extracted from clinical notes and used by an expert to create a vocabulary to represent a clas-
siﬁcation of encoded diseases. (Antonelli et al., 2013) performed a multiple-level clustering
analysis using the DBSCAN algorithm to discover diabetic patients with similar examination
histories. The authors used ICD 9-CM codes.
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Obesity diseases have also been studied by some researchers. The condition is often accom-
panied by comorbidities like diabetes, dyslipidemia, hypertension, cardiovascular diseases,
asthma, and osteoarthritis (Figueroa & Flores, 2016; Foster et al., 2008; Guh et al., 2009).
Works that make a cluster analysis taking account of obesity-related diseases include that by
(Sutherland et al., 2012), which analyzed obesity and asthma. They worked with Ward’s
minimum-variance hierarchical clustering method. They used information from 250 adults
with complete clinical, physiologic and inﬂammatory data. As well, (Laing et al., 2015) ana-
lyzed obesity and atherosclerosis using a statistical method. They used information from 503
patients. Among the features analyzed were extensive family, socio-economic, educational,
personal medical history, physical activity, anthropometric measurements, and laboratory data.
(LaGrotte et al., 2016) analyzed patients with obstructive sleep apnea, obesity, and excessive
daytime sleepiness using statistical analysis. They analyzed the data of 1137 adults, collected
as part of a population-based study of sleep disorders
1.2.2 Limitation of patients cluster analysis
A variety of works analyzing diseases carried out a prospective study with patient information
gathered through direct measures, interviews or questionnaires. A few examples are: (Ahmad
et al., 2014; Chen et al., 2014; Bourdin et al., 2014; Laing et al., 2015; Serrano-Pariente et al.,
2015; LaGrotte et al., 2016). The main difﬁculty with these types of studies lies in their high
cost and the time they require. Additionally, the studies call for training of personnel to collect
information. On the other hand, retrospective studies which consider existing information in
EHR present certain advantages. (Simmons et al., 2016) mention that the use information from
EHR is relatively inexpensive because the data is generated as a result of a healthcare process,
EHR provides long-term information on a variety of diseases, and the information improves as
the record of the same patient grows.
Considering the advantages of information from EHR, a common strategy employed consists
in is using structured data from EHR, such as ICD-9 or ICD-10 (Antonelli et al., 2013; Zhang
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et al., 2014). However, this approach has been deemed inadequate for describing patient phe-
notypes (Shivade et al., 2014). Moreover, a new problem emerges where a disease or medical
condition does not have a speciﬁc code (Anzaldi et al., 2017). To avoid these situations, many
studies suggest exploring unstructured information like clinical notes.
Beyond the challenges inherent to the narrative form of clinical notes (explained in the prob-
lem statement section), information from EHR poses other problems. In their work, (Simmons
et al., 2016) mention difﬁculties stemming from the legacy, sensitivity and conﬁdential char-
acteristics of these resources. Additionally, when a patient visits a different physician at a
different health institution (that does not share the same EHR), the information on the patient’s
health could be incomplete. Furthermore, the authors mention that prospective studies use a
more qualitative data collection method.
The Charlson Comorbidity index and Elixhauser index are patient comorbidity categorization
methods. The methods use diagnostic and administrative data to predict mortality and resource
usage. However, these indexes consider some comorbidities that need empirical observation
and do not scale up for a population with multiple comorbidities (Khan et al., 2018). Many
diseases do not appear in isolation. Multiple risk factors must be analyzed comprehensively to
understand the effects on health outcomes (Bukhanov et al., 2017).
While obesity and other diseases (e.g., diabetes) appear with multiple comorbidities, most
obesity studies, however, focus on the relationship between 2 or 3 comorbidities. Information
of patients suffering multiple medical conditions must be considered. Doing so will make it
possible to study whether a drug has an effect on the appearance of other medical conditions,
if the treatment could lead to a drug interaction, if a treatment for a new patient with similar
characteristics could be prescribed, etc.
Cluster analysis studies have been considered features pre-established by the literature or by
health experts, but clinical notes contain hidden features and associations that could be un-
locked by NER. Clinical notes, as earlier mentioned, are writings from health professionals.
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Such notes therefore have more details on the patient’s health as well as on the temporal evo-
lution of the disease or treatment.
1.2.3 A network-based approach to medical entity analysis
A strategy used to visualize associations among medical entities and infer medical knowledge
is a network-based approach. This method has been used in the biomedical ﬁeld to understand
gene, drug, disease and vaccine, associations and interactions (Pavlopoulos et al., 2018).
Many works have considered clinical data. (Lyalina et al., 2013) used network methods to
visualize the association between symptoms or clinical ﬁndings related to neuropsychiatric
disorders; (Roque et al., 2011) visualized clusters of psychiatric patients; (Chen & Xu, 2014)
ﬁrst extracted association rules for comorbidity patterns of colorectal cancer, after which, a
network method was applied to construct a human disease comorbidity network. The work of
(Khan et al., 2018) created networks to identify comorbidities and conditions related with type
2 diabetes. They worked with diabetic and nondiabetic cohorts to discover comorbidities ex-
clusive of diabetic patients. Similarly, (Kalgotra et al., 2017) identiﬁed comorbidities classiﬁed
by gender. They worked with information on diagnostics, symptoms, and treatments. Addi-
tionally, (Merrill et al., 2015) used a network approach based on information from inpatient
and outpatient clinical services to identify care patterns for congestive heart failure. (Zhao et
al., 2017) manually annotated medical entities from medical records to construct a network that
was used to propose a diagnosis model. (Rotmensch et al., 2017) ﬁrst extracted diseases and
symptoms from structured and unstructured clinical notes. They then constructed a statistical
model with the information extracted, and then translated the models learned into knowledge
graphs.
The identiﬁcation of communities in networks helps to uncover unknown topics in information,
social communities, patterns or themes in medical information. (Gangopadhyay et al., 2016)
divided a network of terms extracted from clinical notes using communities identiﬁcation.
They identiﬁed main terms related to each sub-graph, and presented results related to anemia.
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The bipartite networks is another important concept. In the biomedical ﬁeld, one partition
could represent genes, proteins, molecules, drugs, or environmental exposures, and the other
partition could represent diseases, symptoms, or adverse drug effects (Pavlopoulos et al., 2018).
(Goh et al., 2007) used a bipartite graph consisting of diseases and genes nodes to construct
a diseasome. A disease and gene were connected if mutations in that gene were involved in
the disease. In addition, (Bhavnani et al., 2011) used bipartite networks to represent asthma
patients and cytokines as nodes, with the normalized cytokine expression values being the
edges. They identiﬁed cytokine clusters and their relationship to patient clusters, and drew
biological meanings about the patient clusters.
1.2.4 Limitation of network-based approach to medical entities analysis
Recent years have seen an increase in the number of works that analyze clinical information fol-
lowing a network approach. Some works research the relationship between symptoms, diseases
and drugs, diseases and genes, and others conduct research on the comorbidities or patterns of
a speciﬁc disease. However, most works, similarly to the case of patients cluster analysis, use
structured information obtained from EHR, or through patient measures, interviews or ques-
tionnaires.
Furthermore, works that include genes as features also take the information from databases or
catalogues such as the On-line Mendelian Inheritance in Man (OMIN), Genome-Wide Asso-
ciation Studies (GWAS), National Institutes of Health’s Genetic Association Database (GAD),
Human Genome Organisation (HUGO), and Phenome-Wide Association Studies (PHeWA).
All these catalogues comprise structured information.
Unstructured information within clinical notes must therefore be analyzed and explored with a
network-based approach.
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1.2.5 Sparse K-means
(Bukhanov et al., 2017) describe some of the goals of cluster analysis of patients’ information.
They include the following:
- To ﬁnd clusters based on demographic data, risk factors and comorbid diseases.
- To determine recommendations for diagnostics and treatment of diseases base on the cluster
information.
- To identify similarities and difference between the clusters.
- To ﬁnd predictors of treatment responses depending on the patient’s proﬁle, clustering re-
sults and a combination of recommendations.
Sparse K-means algorithm developed by (Witten & Tibshirani, 2010) helps to simultaneously
ﬁnd clusters and a subset of cluster features. This algorithm assigns a weight to each feature,
with the most important ones having the highest values. Sparse K-means can handle either a
number of features greater than the number of observations or vice-versa. Also, the algorithm
is useful when the dataset has noise variables, and it is characterized by the following criterion:
maximize
C1,...,CK ,w
{ p
∑
j=1
wj
(
1
n
n
∑
i=1
n
∑
i′=1
di,i′, j−
K
∑
k=1
1
nk ∑i,i′∈Ck
di,i′, j
)}
(1.4)
subject to ‖w ‖2≤ 1,‖ w ‖1≤ s,wj ≥ 0∀ j, where, w are non-negative weights for the p features
and n is the number of observations. The weights will be sparse for an appropriate choice of
the tuning parameter s.
Before use sparse k-means, the number of clusters needs to be determined. Gap statistics is a
standard method for detecting the number of clusters. The method compares the within-cluster
dispersion to its expectation under an appropriate reference null distribution (Tibshirani et al.,
2001). These authors deﬁne the gap statistics with the following equations:
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The sum of the pairwise distances Dr of all elements i,i’ in a cluster Cr is as follows:
Dr = ∑
i,i′∈Cr
di,i′ (1.5)
The pooled within-cluster sum of squares around the cluster means is deﬁned as Wk:
Wk =
k
∑
r=1
1
2nr
Dr (1.6)
where k is the number of clusters, n represents the number of observation, and r denotes cluster
indices.
Then, the gap statistic is deﬁned by the equation:
Gapn(k) = E∗n{log(Wk)}− log(Wk), (1.7)
where E∗n denotes expectation under a sample of size n from the reference distribution.
To evaluate a cluster analysis, the Silhouette coefﬁcient is commonly used. Silhouette allows
knowing the intra-cluster cohesion and the inter-cluster separation. (Rousseeuw, 1987) deﬁnes
this coefﬁcient as follows:
a(i) = average dissimilarity of i to all other objects of a cluster A.
d(i,C) =average dissimilarity of i to all other objects of clusters C. C 	= A.
b(i) = minC 	=Ad(i,C) b(i) is the minimum average distance from i to other clusters different
from the cluster to which i belongs.
The silhouette coefﬁcient s(i) is deﬁned as:
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s(i) =
b(i)−a(i)
max{a(i),b(i)} (1.8)
a(i) reﬂects the compactness of the cluster to which i belongs. A small value means that the
cluster is more compact. The value of b(i) represents the degree to which i is separated from
other clusters. Therefore, if b(i) has a large value, then i is more separated from other clusters
(Han et al., 2011).
The Silhouette coefﬁcient is a value between -1 and 1. If the Silhouette value is closer to 1, the
cluster is compact and well separated from other clusters, and objects in the cluster are well
assigned. If the Silhouette value is closer to -1, the cluster is not well separated from other
clusters, and objects in it are wrongly assigned. When the Silhouette is closer to zero, it is not
clear if the objects have been assigned to the actual cluster or to another cluster (Rousseeuw,
1987).
It is important to note that sparse K-mean is still being improved by some research. For ex-
ample, (Kondo et al., 2016) worked with a robust sparse K-means (RSKM) to handle outliers.
RSKM, as well as Sparse K means, gap statistic, and Silhouette are implemented in R.
1.2.6 Network and graph theory
A network is a structure formed by an ordered pair G = ( V , E ). V is a set of vertices or nodes.
E is a set of edges or connections between the nodes. A node could represent any discrete
entity (e.g. an individual or an event), and an edge indicates a relationship between nodes
(Merrill et al., 2015; Kalgotra et al., 2017). Therefore, different systems can be represented
by networks, such as the transport systems in a city, the relationships between members of
a social media platform, the interaction between genes or proteins, the relationship between
drugs, patients, etc.
An adjacency matrix A is a way to represent a graph G. A is a square matrix where an element
Aij is 1 when there is an edge from node i to node j and 0 when there are no edges. For a
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simple graph, the diagonal elements of the matrix A are 0. This graph representation allows a
computational analysis.
Due to the huge amount of information that can be represented and visualized by a network,
an approach to analyzing this information involves decomposing the networks into highly in-
terconnected communities or set of nodes (Newman, 2006). This community detection, also
called network clustering, uses a modularity function with a scalar value between -1 and 1. A
positive value indicates the possible presence of a community structure (Blondel et al., 2008;
Newman, 2006).
Another concept of interest in this study is the bipartite graph. In this graph, nodes are divided
in two non-overlapping sets, and the edges only join two nodes in different sets (Chang & Tang,
2014; Guimera et al., 2007). This network is useful for representing different types of objects.
In biomedical ﬁelds, a bipartite graph can represent drugs and diseases, genes and diseases,
symptoms and diseases, vaccines and gene networks (Pavlopoulos et al., 2018), and so on.
In Gephi, the modularity function is implemented with the algorithm of (Blondel et al., 2008).
1.3 Obesity Dataset
In this thesis, the i2b2 Obesity Dataset was used. The i2b2 (Informatics for Integrating Biology
to the Bedside) made a call for an Obesity Challenge in 2008. This challenge is a multi-class,
multi-label classiﬁcation task focused on obesity and its comorbidities. The available dataset
consists of 1237 discharge summaries from the Partners HealthCare Research Patient Data
Repository. The de-identiﬁcated summaries are from patients who were overweight or diabetic
and had been hospitalized for obesity or diabetes (Uzuner, 2009).
The dataset has annotations on obesity and ﬁfteen obesity comorbidities: asthma, atheroscle-
rotic cardiovascular disease (CAD), congestive heart failure (CHF), depression, diabetes mel-
litus (DM), gallstones/cholecystectomy, gastroesophageal reﬂux disease (GERD), gout, hyper-
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cholesterolemia, hypertension (HTN), hypertriglyceridemia, obstructive sleep apnea (OSA),
osteoarthritis (OA), peripheral vascular disease (PVD), and venous insufﬁciency.
The data were annotated by two experts working on two different types of annotations. (Uzuner,
2009) provides a complete description of the annotations. Here is a brief description: (1) a tex-
tual annotation where the experts classify each disease as Present, Absent, Questionable, or
Unmentioned based on explicitly documented information in the discharge summaries, (2) an
intuitive annotation where the experts classify each disease as Present, Absent, or Questionable
by applying their intuition and judgement to information in the discharge summaries.
To access the i2b2 Obesity dataset, I signed the Data Use and Conﬁdentiality Agreement from
i2b2.
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Abstract
Background: Clinical notes such as discharge summaries have a semi- or unstructured for-
mat. These documents contain information about diseases, treatments, drugs, etc. Extracting
meaningful information from them becomes challenging due to their narrative format. In this
context, we aimed to compare the automatic extraction capacity of medical entities using two
tools: MetaMap and cTAKES.
Methods: We worked with i2b2 (Informatics for Integrating Biology to the Bedside) Obesity
Challenge data. Two experiments were constructed. In the ﬁrst one, only one UMLS concept
related with the diseases annotated was extracted. In the second, some UMLS concepts were
aggregated.
Results: were evaluated with manually annotated medical entities. With the aggregation pro-
cess the result shows a better improvement. MetaMap had an average of 0.88 in recall, 0.89
in precision, and 0.88 in F-score. With cTAKES, the average of recall, precision and F-score
were 0.91, 0.89, and 0.89, respectively.
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Conclusions: The aggregation of concepts (with similar and different semantic types) was
shown to be a good strategy for improving the extraction of medical entities, and automatic
aggregation could be considered in future works.
Keywords: cTAKES; MetaMap; UMLS; Clinical documents.
2.1 Background
Electronic Health Records (EHR) or Electronic Medical Records (EMR) save patients’ infor-
mation in a format that is either structured (e.g., diagnosis codes, laboratory results, med-
ication) or unstructured (e.g., clinical notes). Clinical notes, such as discharge summaries,
radiology notes, and progress notes, have an unstructured format with a narrative style. These
documents provide a more complete portrait of the patient’s health (Roque et al., 2011; Lyalina
et al., 2013; Alnazzawi et al., 2015), as well as additional valuable information (e.g., diagno-
sis, symptoms, medical history, social history, medication, lab tests, treatments, etc.). Un-
fortunately, unstructured formats complicate information extraction. First, they contain many
abbreviations, acronyms, and specialized terms (Chiaramello et al., 2016) . Secondly, a variety
of natural languages are used, depending on the particular health professional or institution
(Pereira et al., 2013), and may not correspond to a general domain. Furthermore, manual an-
notations and analysis present in clinical notes can transform extraction into a time-consuming,
labor-intensive, and error-prone endeavor (Savova et al., 2010).
Nowadays, various tools exist for extracting information from clinical texts created in an un-
structured format. Two such tools, which are widely used and known in the biomedical ﬁeld,
are MetaMap and cTAKES (Pradhan et al., 2015; Kovacevic et al., 2013). MetaMap was de-
veloped by the National Library of Medicine (NLM) to map biomedical text to concepts in the
Uniﬁed Medical Language System (UMLS) (Aronso, 2001; Aronson & Lang, 2010). The tool
uses a hybrid approach combining a natural language processing (NLP), knowledge-intensive
approach and computational linguistic techniques (Aronso, 2001). The Clinical Text Analy-
sis and Knowledge Extraction System (cTAKES) combines rule-based and machine learning
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techniques to extract information from a clinical text (Savova et al., 2010). cTAKES executes
some components in sequence to process the clinical text. Both MetaMap and cTAKES use the
Uniﬁed Medical Language System (UMLS) to extract and standardize medical concepts.
The extraction of medical entities (e.g., diseases, treatments, drugs, etc.) is important for
patients and medical research (Chiaramello et al., 2016; Pradhan et al., 2015; Becker & Bock-
mann, 2016). Moreover, these medical entities form the basis for other tasks such as disease
correlation (Roque et al., 2011), disease classiﬁcation (Yıldırım et al., 2010, 2012) , disease
diagnosis (Pereira et al., 2013; Bejan et al., 2012), phenotype identiﬁcation (Lyalina et al.,
2013; Alnazzawi et al., 2015), etc.
Given the signiﬁcance of medical entity extraction, this paper aims to compare this extraction
carried out using two different tools (MetaMap and cTAKES). For this project, we worked
with the i2b2 (Informatics for Integrating Biology to the Bedside) Obesity Challenge data.
The automated extraction was evaluated against the experts’ manual annotations of 14 obesity
comorbidities (simultaneous presence of two chronic diseases or conditions in a patient) from
discharge summaries.
2.2 Materials and Methods
2.2.1 Dataset
The i2b2 2008 Obesity dataset consists of 1237 discharge summaries of overweight and dia-
betic patients (Uzuner, 2009). The documents contain two different expert annotations: textual
and intuitive. In this work, we use textual annotations where experts classiﬁed 15 obesity co-
morbidities based on the explicit information in discharge summaries. The diseases had four
classiﬁcations:
- Present: The patient has/had the disease.
- Absent: The patient does not/did not have the disease.
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- Questionable: The patient may have the disease.
- Unmentioned: Absence of information of the disease in the discharge summary.
The ﬁrst column of Table 2.1 shows the 14 comorbidities used. Hypertriglyceridemia was
excluded due to a lack of sufﬁcient samples. Out of 1237 summaries, we selected the 412
summaries which had obesity as a comorbidity.
Table 2.1 List of entities or concept
Entities annotated by experts Entities in the ﬁrst experiment Entities or groups in the second experiment
Name of disease Preferred name, CUI, Semantic Type Preferred name, CUI, Semantic Type
Hypertension Hypertensive disease, C0020538, dsyn Hypertensive disease, C0020538, dsyn
Diabetes Diabetes mellitus, C0011849, dsyn
Diabetes mellitus, C0011849, dsyn
Diabetes mellitus, insulin-dependent, C0011854, dsyn
Diabetes mellitus, non-insulin-dependent, C0011860, dsyn
Atherosclerotic Cardiovascular Disease (CAD) Coronary artery disease, C1956346, dsyn
Coronary artery disease, C1956346, dsyn
Coronary arteriosclerosis, C0010054, dsyn
Congestive Heart Failure (CHF) Congestive heart failure, C0018802, dsyn Congestive heart failure, C0018802, dsyn
Hypercholesterolemia Hypercholesterolemia, C0020443, dsyn
Hypercholesterolemia, C0020443, dsyn
Hyperlipidemia, C0020473, dsyn
Obstructive Sleep Apnea (OSA) Sleep apnea obstructive, C0520679, dsyn Sleep apnea obstructive, C0520679, dsyn
Osteoarthritis (OA) Degenerative polyarthritis, C0029408, dsyn Degenerative polyarthritis, C0029408, dsyn
Depression Mental depression, C0011570, mobd
Mental depression, C0011570, mobd
Depressive disorder, C0011581, mobd
Asthma Asthma, C0004096, dsyn Asthma, C0004096, dsyn
Gastroesophageal Reﬂux Disease (GERD) Gastroesophageal reﬂux disease, C0017168, dsyn Gastroesophageal reﬂux disease, C0017168, dsyn
Gallstones/Cholecystectomy Cholecystectomy procedure, C0008320, topp
Cholecystectomy procedure, C0008320, topp
Cholecystolithiasis, C0947622, dsyn
Cholecystitis, C0008325, dsyn
Cholelithiasis, C0008350, dsyn
Gout Gout, C0018099, dsyn Gout, C0018099, dsyn
Peripheral Vascular Disease (PVD) Peripheral vascular diseases, C0085096, dsyn Peripheral vascular diseases, C0085096, dsyn
Venous Insufﬁciency Venous insufﬁciency, C0042485, dsyn
Venous insufﬁciency, C0042485, dsyn
Postthrombotic syndrome, C0277919, patf
CUI: Concept Unique Identiﬁer
The second experiment grouped together some entities related to the disease annotated by the experts.
dsyn = Disease or Syndrome; mobd = Mental or Behavioral Dysfunction; topp = Therapeutic or Preventive Procedure; patf = Pathologic Function
2.2.2 Uniﬁed Medical Language System
The National Library of Medicine Uniﬁed Medical Language System (UMLS) provides termi-
nology, coding standards, and resources for biomedical and electronic health systems. UMLS
has three Knowledge Sources: the Metathesaurus, the Semantic Network and the SPECIALIST
lexicon.
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The Metathesaurus is organized by concepts or meanings. A concept has a unique and perma-
nent identiﬁer (CUI) and a preferred name. The concept is a meaning, and a meaning can have
different names from different vocabularies or thesauruses (National Library of Medicine (US),
2009). The Semantic Network provides (1) a categorization (semantic type) of all concepts
represented in the UMLS Metathesaurus; and (2) a set of relationships (semantic relations)
between these concepts (National Library of Medicine (US), 2009). The Semantic Network
contains 133 semantic types and 54 relationships.
UMLS is based on some electronic thesauruses, classiﬁcations, code sets, and lists of controlled
terms like SNOMED CT and RxNorm (National Library of Medicine (US), 2009). The Sys-
tematized Nomenclature of Medicine - Clinical Terms (SNOMED CT) is a multilingual health
terminology used for the electronic exchange of clinical health information (National Library
of Medicine (US), 2016). In the U.S., SNOMED CT is the national standard for electronic ex-
change of clinical health information (National Library of Medicine (US), 2016). On the other
hand, RxNorm standardizes clinical drug names and links the names to other vocabularies used
in pharmacy management and drug interaction software (National Library of Medicine (US),
2014).
In this work, the medical entities extracted will be the concepts represented by the CUIs. We
worked with SNOMED CT and RxNorm as vocabularies and with four semantic types (hence-
forth ST):
- Disease or Syndrome
- Mental or Behavioral Dysfunction
- Pathologic Function
- Therapeutic or Preventive Procedure
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2.2.3 Automatic Extraction
We used separately MetaMap (version 2015) and cTAKES (version apache-ctakes-3.2) to ex-
tract the CUIs related with the 14 obesity comorbidities above mentioned. With each tool, two
different experiments were carried out to extract the entities automatically.
In the ﬁrst experiment, we identiﬁed one CUI code related to each comorbidity or disease. The
extracted CUI and the preferred name of the concepts are shown in Table 2.1, column 2. In this
experiment, diabetes, atherosclerotic cardiovascular disease (CAD), hypercholesterolemia, os-
teoarthritis, depression, venous insufﬁciency, and cholecystectomy have low values in the eval-
uation (see Table 2.2). Therefore, to improve the results for these diseases, a second experiment
was performed.
In the second experiment, we worked with two types of aggregations described below. Aggre-
gation has been wide applied in the genetic ﬁeld. For example, a pathway level is used instead
of individual genes to obtain a compact representation or to improve tasks like classiﬁcation or
clustering (Hwang, 2012).
1. Aggregation of CUIs with the same ST. The aggregation of CUIs belonging to the ST
“Diseases or Syndromes” allowed us to cover diabetes, coronary artery disease and hyper-
cholesterolemia, while the aggregation of CUIs belonging to the ST “Mental or Behavioral
Dysfunction” allowed us to cover mental depression.
2. Aggregation of CUIs with different ST. First, we aggregated CUIs belonging to the ST
“Diseases or Syndrome” with CUIs belonging to the ST “Pathologic Function”; this group-
ing allowed us to recover enough information to better identify venous insufﬁciency. Sec-
ond, we aggregated CUIs belonging to the ST “Therapeutic or Preventive Procedure” with
CUIs belonging to the ST “Diseases or Syndrome”; this second grouping allowed us to
recover the information needed to identify cholecystectomy. Details of the CUIs grouped
together are shown in Table 2.1, column 3. Figure 2.1 shows the process for the second
experiment and Figure 2.2 shows the aggregation process.
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Figure 2.1 Process for the second experiment. Discharge
summaries were analyzed with MetaMap or cTAKES to extract
CUIs. Then some CUIs were aggregated to obtain the 14
comorbidities related with obesity.
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Figure 2.2 Aggregation process
2.2.4 Evaluation Metrics
We considered the experts’ annotations as a gold standard in evaluating the automatic extrac-
tion. Only the “Present” annotation was taken into account in identifying whether the patient
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has or had the diseases. We used the recall (or sensitivity), precision and F-score to evaluate
the results:
Recall =
TP
TP+FN
(2.1)
Precision=
TP
TP+FP
(2.2)
Fscore= 2
Precision.Recall
(Precision+Recall)
(2.3)
where TP is the number of true positives of the CUIs mentioned, FN is the number of false neg-
atives of the CUIs mentioned, and FP is the number of false positives of the CUIs mentioned.
2.3 Results
In the ﬁrst experiment (see Table 2.2), the averages for the recall, precision and F-score with
MetaMap were 0.78, 0.91, and 0.82, respectively. With cTAKES, the averages for the same
measures were 0.82, 0.91, and 0.84, respectively. MetaMap showed a low recall value for
diabetes (0.65), CAD (0.45), hypercholesterolemia (0.59), and venous insufﬁciency (0.29).
Cholecystectomy presents a satisfactory recall value (0.73) although much lower than the over-
all results. Also, cTAKES had low recall values for hypercholesterolemia (0.51), osteoarthritis
(0.67), and venous insufﬁciency (0.29).
In the second experiment (see Table 2.3), we achieved better results. MetaMap had an average
of 0.88 in recall, 0.89 in precision, and 0.88 in F-score. With cTAKES, the averages for recall,
precision and F-score were 0.91, 0.89, and 0.89, respectively. That means that aggregation
improves the results. For example, in the ﬁrst experiment, diabetes had a recall value of 0.65
(MetaMap) and 0.83 (cTAKES), but in the second experiment, these values increased to 0.89
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(MetaMap) and 0.92 (cTAKES). The same can be said about hypercholesterolemia. In the ﬁrst
experiment, this disease had a recall value of 0.59 (MetaMap) and 0.51 (cTAKES), but in the
second experiment, these values improved to 0.88 and 0.81.
Table 2.2 Summary of ﬁrst experiment
Diseases
Number of patients Evaluation
Annotations MetaMap cTAKES MetaMap cTAKESRecall Precision F-score Recall Precision F-score
Hypertension 325 336 340 0.99 0.96 0.98 0.99 0.95 0.97
Diabetes * 259 186 235 0.65 0.91 0.76 0.83 0.91 0.87
Atherosclerotic Cardiovascular Disease (CAD) * 181 95 199 0.45 0.86 0.59 0.92 0.84 0.88
Congestive Heart Failure (CHF) 172 175 183 0.89 0.87 0.88 0.92 0.86 0.89
Hypercholesterolemia * 172 108 92 0.59 0.94 0.73 0.51 0.95 0.66
Obstructive Sleep Apnea (OSA) 127 105 102 0.78 0.94 0.85 0.76 0.94 0.84
Osteoarthritis (OA) * 87 76 61 0.76 0.87 0.81 0.67 0.95 0.78
Depression * 83 105 116 0.89 0.70 0.79 0.99 0.71 0.82
Asthma 81 83 92 0.93 0.90 0.91 1.00 0.88 0.94
Gastroesophageal Reﬂux Disease (GERD) 76 83 85 0.97 0.89 0.93 0.99 0.88 0.93
Gallstones/Cholecystectomy * 74 54 58 0.73 1.00 0.84 0.78 1.00 0.88
Gout 56 58 58 0.98 0.95 0.96 0.98 0.95 0.96
Peripheral Vascular Disease (PVD) 37 37 32 0.97 0.97 0.97 0.84 0.97 0.90
Venous Insufﬁciency * 21 6 6 0.29 1.00 0.44 0.29 1.00 0.44
AVERAGE 0.78 0.91 0.82 0.82 0.91 0.84
Disease with low evaluation.
The lowest values for recall and precision are in bold.
Table 2.3 Summary of second experiment
Diseases
Number of patients Evaluation
Annotations MetaMap cTAKES MetaMap cTAKESRecall Precision F-score Recall Precision F-score
Hypertension 325 336 340 0.99 0.96 0.98 0.99 0.95 0.97
Diabetes * 259 254 266 0.89 0.91 0.90 0.92 0.89 0.91
Atherosclerotic Cardiovascular Disease (CAD) * 181 130 205 0.60 0.83 0.69 0.92 0.81 0.87
Congestive Heart Failure (CHF) 172 175 183 0.89 0.87 0.88 0.92 0.86 0.89
Hypercholesterolemia * 172 159 146 0.88 0.96 0.92 0.81 0.96 0.88
Obstructive Sleep Apnea (OSA) 127 105 102 0.78 0.94 0.85 0.76 0.94 0.84
Osteoarthritis (OA) 87 76 61 0.76 0.87 0.81 0.67 0.95 0.78
Depression * 83 109 116 0.93 0.706 0.802 0.99 0.71 0.82
Asthma 81 83 92 0.93 0.90 0.91 1.00 0.88 0.94
Gastroesophageal Reﬂux Disease (GERD) 76 83 85 0.97 0.89 0.93 0.99 0.88 0.93
Gallstones/Cholecystectomy * 74 65 68 0.865 0.99 0.92 0.89 0.97 0.93
Gout 56 58 58 0.98 0.95 0.96 0.98 0.95 0.96
Peripheral Vascular Disease (PVD) 37 37 32 0.97 0.97 0.97 0.84 0.97 0.90
Venous Insufﬁciency * 21 27 30 0.905 0.704 0.792 1 0.7 0.824
AVERAGE 0.88 0.89 0.88 0.91 0.89 0.89
* Diseases formed by two or more UMLS concepts.
The values improved are in bold.
34
CAD is a special case which illustrates the difference between both tools. For a sentence
like (1) below, cTAKES recognized, among many other clues, the abbreviation “CAD”, but
MetaMap did not. Consequently, the number of patients with this disease was lower in MetaMap;
however, this notwithstanding, the recall increased from 0.45 to 0.6, which is a direct conse-
quence of the aggregation of ST.
1. “Conditions, Infections, Complications, Affecting Treatment/Stay HTN, CAD, High choles-
terol, OSA, OA, Depression, and Anxiety”
2. “ST depression in the inferior leads and V5-V6”
3. “was found to be in atrial ﬂutter with a 2:1 block and 2-3 mm lateral ST depressions in
V4-V6”
Depression is another interesting case. In the ﬁrst experiment, it was the disease with the
lowest precision in both tools, 0.70 in MetaMap, and 0.71 in cTAKES. Sentences (2) and
(3) above illustrate the problem. For both sentences, MetaMap and cTAKES consider that
the word “depression” refers to the disease, which is clearly not the case. In both sentences,
“depression” refers to a part that is lower than the surrounding area, not to the disease. This
problem increased the number of false positives. Consequently, the aggregation of ST, used in
the second experiment, did not signiﬁcantly increase precision. However, the aggregation of
ST allowed MetaMap to increase the recall from 0.89 to 0.93.
In the ﬁrst experiment, we considered the cholecystectomy procedure, but in order to know
other ways to identify the presence of gallstones, we added information referring to diseases
and syndromes such as cholecystolithiasis, cholecystitis, and cholelithiasis. Therefore, the
second experiment increased the recall from 0.73 to 0.87 (for MetaMap), and from 0.78 to
0.87 (for cTAKES).
Venous insufﬁciency increased its recall from 0.29 to 0.9 (for MetaMap), and from 0.29 to 1
(for cTAKES). To improve the venous insufﬁciency result, we added the postthrombotic syn-
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drome which corresponded to the ST pathologic function. Osteoarthritis or degenerative pol-
yarthritis presented a low recall with cTAKES, bringing us to review the automatic extraction
of the disease. In many cases, health professionals use the abbreviation OA for this disease, an
abbreviation which is not recognized by cTAKES; consequently, the number of patients with
this disease was low as compared to MetaMap. In some cases, MetaMap mapped this disease
to a precise CUI such as C0409959 (Degenerative joint disease of knee), but in other cases,
when the experts classiﬁed the disease as “OA”, MetaMap and cTAKES generalized it using
the general concept “arthritis”. Since osteoarthritis is a speciﬁc type of arthritis, we decided
not to proceed, in that speciﬁc case, with the aggregation of all CUIs under “arthritis”.
2.4 Discussion
Considering the results shown in Table 2.2 (ﬁrst experiment), it is not surprising that previous
authors chose to combine both tools to secure better results (Tang et al., 2013). In this work, we
avoid that combination because we intended to compare the results of each tools. The results
in Table 2.3 (second experiment) show that at least two types of relationships have to be taken
into account to obtain, with both tools, better results.
1. Aggregation of CUIs with the same ST (e.g., “Disease or Syndrome” and "Mental or Be-
havioral Dysfunction"): This form of aggregation takes into account the "isa/inverse_ isa
” relations between concepts in the Metathesaurus. This relation, allowed us to group
under “diabetes mellitus”, both “insulin-dependent-diabetes” and “non-insulin-dependent-
diabetes”. Similarly, “coronary arteriosclerosis” was grouped with “coronary artery dis-
ease”, “hyperlipidemia” with “hypercholesterolemia”, and “depressive disorder” with “men-
tal depression”.
2. Aggregation of CUIs with different ST: An example here is using the Metathesaurus re-
lation “due_ to/caused_ by” to combine venous insufﬁciency disease with the postthrom-
botic syndrome pathologic function. Also, we noted that for many forms of gallstones,
the clinical notes mentioned the cholecystectomy procedure instead of the speciﬁc disease
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(e.g., cholecystolithiasis). Using the relation “clinically_ associated_ with”, we were able
to connect the cholecystectomy procedure with the cholelithiasis disease, and then with
the cholecystolithiasis and cholecystitis diseases, among others.
Tables 2.2 and 2.3 show the results of the ﬁrst and second experiments. Overall, the aggre-
gations carried out in the second experiment increased the F-score by 7.3% for MetaMap,
and by 6% for cTAKES. The recall values increased by 12.8% for MetaMap and by 11% for
cTAKES, while the precision values decreased slightly in both tools, -2.2% for both MetaMap
and cTAKES.
As we mentioned above, clinical notes contain many abbreviations, acronyms, and specialized
terms that renders difﬁcult the extraction of patient information. Abbreviations such as CHF
and PVD were identiﬁed by both tools, but CAD and OA were not. It means that the results are
sensitive to abbreviations used in the clinical notes. To resolve this problem, MetaMap allows
users to deﬁne a list of abbreviations and acronyms. On the other hand, cTAKES does not have
such a list (Jonnagaddala et al., 2016). In this work, we did not use any list of abbreviations
with the aim to keep the same conﬁguration for both tools, but the use of this option could help
MetaMap improve its results.
In the annotations made by the experts, they used general names or maybe a preferred name
to denote a comorbidity. For that reason, in the second experiment, we had to look for some
UMLS concept to identify one annotated comorbidity (e.g. we matched 3 UMLS diabetes mel-
litus concepts). In other cases, we worked with different semantic types such as pathological
function and therapeutic or preventive procedures to referred to a comorbidity mentioned by
the experts (e.g. venous insufﬁciency and gallstones).
2.5 Future Works
In future works, we will consider the automatic aggregation of concepts or CUIs using the
relations between the concepts described in the Metathesaurus and the semantic relation present
in the Semantic Network.
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Also, while clinical notes hold information on many medical entities, some of them are in
negative contexts (e.g., “The patient does not have diabetes”). In this work, we did not use
algorithms like NegEx (Chapman et al., 2001) that permit a recognition of entities in negative
contexts. Moreover, for the extraction of medical entities, all sections were considered, includ-
ing the parts such as family history, which can describe diseases that the patient does not have.
Therefore, these characteristics can be taken into account to decrease the rate of false positives
and improve precision.
2.6 Conclusion
In this paper, we compared the automatic extraction of 14 obesity comorbidities using MetaMap
and cTAKES. Automatic extraction was compared to manual annotation by experts. The result
of the experiments we conducted proved that cTAKES slightly outperforms MetaMap, but this
situation could change considering other conﬁguration options that each tool has such as the
abbreviations list in the MetaMap tool. Moreover, we worked with two types of aggregations:
aggregation of CUIs with the same semantic type and aggregation of CUIs with different se-
mantic types. These groups improve the results. Hence, the use of cTAKES or even MetaMap,
using the proposed aggregations, can represent a good strategy to replace the manual extraction
of medical entities.
Finally, it should be noted that both tools are constantly improving the quality of their results.
However, we believe that the combination of both, along with the aggregations, might even
permit to cover complementary cases where both tools give different results.
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Abstract: Clinical notes provide a comprehensive and overall impression of the patient’s
health. However, the automatic extraction of information within these notes is challenging due
to their narrative style. In this context, our goal was to identify clusters of patients based on
fourteen comorbidities related to obesity, automatically extracted with the cTAKES tool from
the i2b2 Obesity Challenge data. Furthermore, results were compared with clusters obtained
from experts’ annotated data. The sparse K-means algorithms were used in both experiment
at two levels: at the ﬁrst level, three clusters were found, and at the second, new clusters were
found by applying the same algorithm to each of the clusters from the former level. The results
show that three types of clusters could be identiﬁed based on the number of comorbidities and
the percentage of patients suffering from them. Diabetes, hypercholesterolemia, atheroscle-
rotic cardiovascular diseases, congestive heart failure, obstructive sleep apnea, and depression
were the diseases with the highest weights contributing to the cluster distribution.
Keywords: Obesity, clinical notes, cTAKES, cluster analysis.
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3.1 Introduction
Patients’ information, including diseases, symptoms, treatments, drugs, etc., can be derived
from clinical notes such as discharge summaries. These documents have a narrative format,
which allows the health professional to write in a ﬂexible manner. These notes contain local
dialectal phrases, negations, acronyms, abbreviations, misspellings and typing errors, which all
make it difﬁcult to automatically extract patients’ information from them (Shivade et al., 2014;
Bukhanov et al., 2017).
Manual extraction of patient information is carried out by experts, and is laborious and time-
consuming. Even automatic extraction is extremely difﬁcult because the information sought
is hidden within signiﬁcant amounts of data residing in clinical notes (Shivade et al., 2014).
The process of getting structured medical information requires extracting named entities or
concepts and then mapping them to codes according to controlled vocabulary or medical stan-
dards (Bukhanov et al., 2017). Two standards used to map biomedical concepts are the Uniﬁed
Medical Language System (UMLS) (National Library of Medicine (US), 2009) and the Sys-
tematized Nomenclature of Medicine - Clinical Terms (SNOMED-CT) (National Library of
Medicine (US), 2016). Clinical features, such as comorbidities (simultaneous presence of two
diseases or conditions in a patient) related to a speciﬁc disease, are important features and are
at the root of other tasks such as cluster analysis.
In the medical ﬁeld, cluster analysis helps in identifying and tailoring treatment or care de-
livery, deﬁning boundaries and disease taxonomies, understanding the heterogeneity of the
disease, identifying subsets of patients with similar characteristics, identifying relevant patho-
physiologies, etc. (Bourdin et al., 2014; Chen et al., 2014; Rocha & Rocha, 2014; van der
Esch et al., 2015). Many authors have applied cluster analysis to various conditions, such as
obstructive sleep apnea (Joosten et al., 2012; Vavougios et al., 2016), asthma (Bourdin et al.,
2014; Serrano-Pariente et al., 2015), knee osteoarthritis (van der Esch et al., 2015), chronic
heart failure (Ahmad et al., 2014), and chronic obstructive pulmonary diseases (Chen et al.,
2014).
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Overweight and obesity are a global health problem that is becoming an epidemic in both
children and adults (Poirier et al., 2006). Obesity is often accompanied by other health risks
or comorbidities such as diabetes, dyslipidemia, hypertension, cardiovascular diseases, asthma
and osteoarthritis (Figueroa & Flores, 2016; Foster et al., 2008; Guh et al., 2009).
Cluster analysis studies that take into account diseases related to obesity include that by Suther-
land et al. (Sutherland et al., 2012), which identiﬁed clusters of patients suffering from obesity
and asthma simultaneously. Laing et al. (Laing et al., 2015) analyzed the relationship between
obesity and atherosclerosis, while LaGrotte et al. (LaGrotte et al., 2016) focused on patients
with obstructive sleep apnea, obesity, and excessive daytime sleepiness.
Notwithstanding the presence of multiple comorbidities in obese patients, most of the related
works focus on analyzing the relationship between 2 comorbidities instead of 14. Furthermore,
all the features in the above works were collected manually or from structured EHR data despite
the signiﬁcant amount of information inside clinical notes. The motivation for this work was
therefore to apply cluster analysis to obesity comorbidities in order to gain insights into the
different types of obese patients that can exist according to the number of comorbidities they
have.
Based on the above explanation, the goal of our work is to identify clusters of obese patients
based on obesity comorbidities extracted from clinical notes automatically. In addition, a clus-
ter analysis based on the comorbidities annotated by experts from the same dataset was devel-
oped in order to allow a comparison with the cluster analysis result from the extracted data. The
i2b2 (Informatics for Integrating Biology to the Bedside) Obesity Challenge data was used.
3.2 Materials and Methods
In this section, we will describe the dataset used and the process for expert annotation and
automatic extraction. We will also explain the cluster analysis.
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3.2.1 Dataset
We used the i2b2 2008 Obesity dataset. This dataset consists of 1237 discharge summaries
of overweight and diabetic patients (Uzuner, 2009). The documents in the dataset contain
expert annotations that classify 15 obesity comorbidities as present, absent, questionable or
unmentioned (Uzuner, 2009). Table 3.1, column 1, shows the 14 comorbidities (known as
diseases hereinafter) used. Hypertriglyceridemia does not have sufﬁcient samples, and was
therefore excluded. Out of 1237 summaries, 412 summaries which had obesity and at least one
of the 14 diseases were selected. The last preselection was made to avoid samples with 0 in all
the columns, because in the dataset obtained with the automatic extraction, there were some
cases where the patients showed obesity without another comorbidity. Also, in this work, we
wanted to keep the same patients that were selected in our previous work (Reátegui & Ratté,
2018b).
3.2.2 Experts’ Annotation and Automatic Entity Extraction
In our previous work (Reátegui & Ratté, 2018b), the cTAKES and MetaMap tools were com-
pared in the extraction process of 14 obesity comorbidities. Also, experts’ textual annotations
were used as a gold standard. The comorbidities were treated as dichotomy variables or fea-
tures (values of 0 or 1, respectively depicting the non-existence or existence of the disease in
discharge summaries). The results showed cTAKES slightly outperforming MetaMap. In this
work, therefore, we decided to use the results obtained with cTAKES, together with the expert
annotations to identify clusters of obese patients. These results also consider an aggregation
process and some semantics types. Table 3.1 shows the expert annotations and the cTAKES re-
sults. The average for recall, precision and F-score are 0.91, 0.89, and 0.89, respectively. More
details of the extraction and aggregation processes are given in (Reátegui & Ratté, 2018b).
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Table 3.1 Diseases annotated by experts and extracted
with MetaMap. Reátegui, R., Ratté, S. (2018)
Comparison of MetaMap and cTAKES for entity
extraction in clinical notes. BMC medical informatics
and decision making 18 (Suppl 3):74.
doi:10.1186/s12911-018-0654-2
Diseases Experts’ annotation cTAKES Extraction Evaluation
NP (*) %(*) NP % Recall Precision F-score
Hypertension 325 79 340 83 0.99 0.95 0.97
Diabetes 259 63 266 65 0.92 0.89 0.91
CAD 181 44 205 50 0.92 0.81 0.87
CHF 172 42 183 44 0.92 0.86 0.89
HCL 172 42 146 35 0.81 0.96 0.88
OSA 127 31 102 25 0.76 0.94 0.84
OA 87 21 61 15 0.67 0.95 0.78
Depression 83 20 116 28 0.99 0.71 0.82
Asthma 81 20 92 22 1.00 0.88 0.94
GERD 76 18 85 20 0.99 0.88 0.93
CCY 74 18 68 17 0.89 0.97 0.93
Gout 56 14 58 14 0.98 0.95 0.96
PVD 37 9 32 8 0.84 0.97 0.90
VI 21 5 30 7 1 0.7 0.824
Evaluation Results Average: 0.91 0.89 0.89
(*) Number and percentage of patients with the disease.
CAD: atherosclerotic cardiovascular diseases; CHF: congestive heart failure;
HCL: hypercholesterolemia; OSA: obstructive sleep apnea; OA: osteoarthritis;
GERD: gastroesophageal reﬂux disease; CCY: cholecystectomy;
PVD: peripheral vascular disease; VI: venous insufﬁciency.
3.2.3 Cluster Analysis
Sparse K-means clustering developed by (Witten & Tibshirani, 2010) was chosen to conduct
two experiments: a cluster analysis using the automatic extracted data and a cluster analysis
using the experts’ annotated data. The sparse K-means has the advantage of allowing an accu-
rate identiﬁcation of the groups and providing interpretable results following the identiﬁcation
of the most relevant clustering features (Witten & Tibshirani, 2010). This algorithm assigns
a weight to each disease (used as features by the algorithm), with the diseases that contribute
the most to a cluster having the highest values. Before using sparse K-means, we applied gap
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statistics (Tibshirani et al., 2001) to estimate the number of clusters. Cluster analysis was per-
formed at two levels in both experiments: in the data extracted and in the annotated data. At
the ﬁrst level, sparse K-means was applied to all 412 patients, resulting in three clusters. At
the second level, the same algorithm was applied to each of the three clusters of the ﬁrst level.
The second level gave us a total of 11 clusters. Fig. 3.1 shows their distribution and the cluster
equivalence between both experiments.
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Figure 3.1 Cluster analysis by levels. The numbers in
parentheses are the patients in each cluster. EC clusters are from
the extracted data and AC clusters are from annotated data.
3.3 Results
In this section, we will detail the results of the cluster analysis. Fig. 3.1 shows the distribu-
tion of the clusters of both experiments, along with the correspondence between the clusters
according to the highest percentage of patients suffering from a disease.
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3.3.1 Cluster Analysis with Extracted Data
The ﬁrst level had 3 clusters (See Table 3.2), and the diseases with the highest weights were
hypercholesterolemia and diabetes. These clusters had the following characteristics: EC1 had
159 patients, all of them had diabetes, and 79% had hypertension. A moderate percentage had
CAD (52%) and CHF (43%). There were no patients with hypercholesterolemia. EC2 had 107
patients, 80% had hypertension, and a moderate percentage had CHF (38%). There were no
patients with diabetes and hypercholesterolemia. EC3 had 146 patients, all of them had hy-
percholesterolemia, 88% had hypertension, 73% had diabetes, 66% had CAD, and a moderate
percentage had CHF (51%). In these big groups, it is easy identify obese patients with hyper-
tension, diabetes and without hypercholesterolemia (EC1), obese patients with hypertension
and without diabetes and hypercholesterolemia (EC2), and obese patients with hypertension,
diabetes, CAD, and hypercholesterolemia (EC3). Other diseases are present in moderate and
low rates. At the second level from EC1, 3 clusters were obtained: EC1.1, EC1.2, and EC1.3.
The diseases with the highest weights were CAD and depression. From EC2, 4 clusters were
obtained: EC2.1, EC2.2, EC2.3 and EC2.4. The diseases with the highest weights were CHF
and OSA. From EC3, 4 clusters were obtained: EC3.1, EC3.2, EC3.3 and EC3.4. The diseases
with the highest weights were CAD and CHF. Table 3.3 shows the results at the second level.
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Table 3.2 Clusters from the ﬁrst level
CLUSTERS WITH EXTRACTED DATA CLUSTERS WITH ANNOTATED DATA
DISEASES
NUM
PATIENTS
DW EC1 (HC) EC2 (MC) EC3 (HC)
NUM
PATIENTS
DW AC1 (HC) AC2 (MC) AC3 (HC)
Hypertension 340 0 79 80 88 325 0 73 72 87
Diabetes 266 0.23 100 0 73 259 0.23 100 0 72
CAD 205 0 52 25 66 181 0 45 17 59
CHF 183 0 43 38 51 172 0 44 34 45
HCL 146 0.97 0 0 100 172 0.97 0 0 100
OSA 102 0 24 29 23 127 0 30 42 24
OA 61 0 9 20 17 87 0 11 30 23
Depression 116 0 32 24 27 83 0 28 20 14
Asthma 92 0 18 30 22 81 0 17 27 17
GERD 85 0 17 20 25 76 0 14 16 23
CCY 68 0 13 21 17 74 0 14 22 19
Gout 58 0 15 14 13 56 0 15 14 12
PVD 32 0 11 2 9 37 0 13 6 8
VI 30 0 6 7 8 21 0 3 5 7
Patients per Cluster 159 107 146 135 105 172
The cluster results are represented in percentages according to the number of patients in each group.
The Disease Weights (DW) show the weights that sparse K-means assigns to each disease.
Bold numbers are the highest values.
HC: High Comorbidity; MC: Medium Comorbidity
CAD: atherosclerotic cardiovascular diseases; CHF: congestive heart failure; HCL: hypercholesterolemia;
OSA: obstructive sleep apnea; OA: osteoarthritis; GERD: gastroesophageal reﬂux disease; CCY: cholecystectomy;
PVD: peripheral vascular disease; VI: venous insufﬁciency.
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3.3.2 Cluster Analysis with Annotated Data
A cluster analysis using the experts’ annotated data was carried out to compare the results
obtained with the automatic extracted data. As in the above experiment, the ﬁrst level had
3 clusters, AC1, AC2, and AC3. The diseases with the highest weights were hypercholes-
terolemia and diabetes. These new clusters compared with the clusters from the extracted data
(at the ﬁrst level) show a small difference in the percentage of the patients suffering from a
speciﬁc disease. See Table 3.2 for more details. At the second level from AC1, 3 clusters were
obtained: AC1.1, AC1.2, and AC1.3. The diseases with the highest weights were CAD and
OSA. From AC2, 4 clusters were obtained: AC2.1, AC2.2, AC2.3 and AC2.4. The diseases
with the highest weights were hypertension and OSA. From AC3, 4 clusters were obtained:
AC3.1, AC3.2, AC3.3 and AC3.4. The diseases with the highest weights were CAD and CHF.
The difference between these new clusters and those obtained with the extracted data lies in the
fact that with the new ones, we have a new distribution of clusters AC1 based on OSA diseases
and of clusters AC2 based on hypertension diseases. Table 3.4 shows the results at the second
level.
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3.3.3 Cluster Classiﬁcation
Based on an observation of the clusters, and considering the number of diseases (comorbidities)
and the percentage of patients with them, three types of comorbidities were identiﬁed:
- High comorbidity: Occurs when a cluster has one of the following characteristics: (1) Three
or more diseases with a high percentage of patients (67% to 100%); (2) Two diseases with
a high percentage of patients (67% to 100%) and one or more diseases, with 33% to 66%
of the patients suffering from them.
- Medium comorbidity: Occurs when a cluster has one of the following characteristics: (1)
Two diseases with a high percentage of patients (67% to 100%); (2) One disease with a
high percentage of patients (67% to 100%) and one or more diseases, with 33% to 66% of
patients suffering from them.
- Low comorbidity: Occurs when a cluster has one of the following characteristics: (1) One
disease with a high percentage of patients (67% to 100%); (2) One or more diseases in the
33% to 66% range or between 0% to 32% .
Given the above explanations, and considering the clusters obtained with the extracted data,
at the ﬁrst level, EC1 and EC3 have a high comorbidity, and EC2 has a medium comorbidity.
At the second level, EC1.1 and EC1.2 have a high comorbidity, and EC1.3 has a medium
comorbidity; EC2.1 has a high comorbidity, EC2.2 and EC2.4 have high comorbidity, and
EC2.3 has a low comorbidity, and EC3.1, EC3.2, EC3.3, and EC3.4 have a high comorbidity.
Considering the clusters obtained with the annotated data, at the ﬁrst level, AC1 and AC3
have a high comorbidity, and AC2 has a medium comorbidity. At the second level, AC1.2
and AC1.3 have a high comorbidity, and AC1.1 has a medium comorbidity; AC2.2 has a high
comorbidity, AC2.1 and AC2.3 have medium comorbidity, and AC2.4 has a low comorbidity;
AC3.1, AC3.2, AC3.3, and AC3.4 have a high comorbidity.
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3.4 Discussion
To get a medical interpretation of the clusters obtained with the extracted data, two physicians
were asked to express their opinion about Table 3.2 and Table 3.3. They provided the comments
below. Fig. 3.2 shows the diseases with a high percentage of patients in each sub-cluster.
EC1.1 (51)
Diabetes
Depression
Hypertension
EC1.2 (54)
Diabetes
CAD
Hypertension
EC1.3 (54)
Diabetes
Hypertension
EC3.1 (54)
HCL
CHF
CAD
Hypertension
Diabetes
EC3.2 (42)
HCL
CAD
Hypertension
Diabetes
EC3.3 (20)
HCL
CHF
Hypertension
Diabetes
EC3.4 (30)
HCL
Hypertension
Diabetes
EC2.1 (14)
CHF
OSA
Hypertension
EC2.2 (27)
CHF
Hypertension
EC2.3 (49)
Hypertension
EC2.4 (17)
OSA
Hypertension
EC1 (159) EC2 (107)
EC3 (146)
Figure 3.2 Diseases with a high percentage (67 to 100%) of patients in each
sub-cluster.
Considering the percentage of patients with a comorbidity, hypertension, diabetes, CAD, CHF,
HCL and OSA have the highest values. These results agree with previous works such as (Bruce
et al., 2011; Guh et al., 2009; Poirier et al., 2006) which show the common comorbidities
related to obesity and overweight people.
In cluster EC1, all patients have diabetes. Also, all EC3 incorporate more than 70% of diabetic
patients. Although the experiment does not detail the type of diabetes, we could mention the
high association of type 2 diabetes with obesity. More than 80% of cases of type 2 diabetes can
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be attributed to obesity that causes insulin resistance, and ultimately, hyperglycemia (Willett
et al., 1999). Although metformin (one of the drugs most commonly used in the treatment
of type 2 diabetes) causes weight reduction, some drugs used in type 2 diabetes can cause
moderate increases in weight (Leslie et al., 2007).
In cluster EC2, all the patients do not have diabetes and HCL. This cluster has the highest per-
centage (29%) of patients with OSA. OSA is a disorder that occurs during sleep, in which the
patient experiences repetitive episodes of apnea (stops breathing) or a reduction of airﬂow due
to an obstruction of the upper airway. Obesity is the most potent risk factor in the development
of OSA, and its relative risk increases as the body mass index (BMI) increases (Peppard et al.,
2013). In EC2.1 and EC2.4, all the patients have OSA with comorbidities such as hypertension
and CHF. These diseases, among others, were identiﬁed as comorbidities in OSA patients in
the work of (Vavougios et al., 2016). The prevalence of cardiovascular risk factors such as hy-
pertension and type 2 diabetes is substantially higher in patients with OSA. OSA is a clear risk
factor for cardiovascular events, although it is not entirely clear whether it is due to its high as-
sociation with obesity and other coexisting factors (Wolf et al., 2007). This could explain why
not all patients with OSA are present in this cluster, while 24% and 23% of OSA patients are in
EC1 and EC3, which have patients with other OSA comorbidities such as diabetes and CAD.
Also, EC2 has the highest percentage of hypertensive patients (80%); this can be explained by
the fact that hypertension is independently associated with OSA.
In EC3, we ﬁnd 100% of patients with HCL. Furthermore, this cluster has the highest per-
centage of patients with hypertension and CAD. The risk of CAD is higher in obese people.
Most experts attribute part of this relationship to the coexistence of risk factors, although the
American Heart Association considers obesity as an independent risk factor for CAD (Poirier
et al., 2006). In the same cluster, for example, 88% of patients have hypertension, 73% have
diabetes, and 100% have HCL. These are precisely the main risk factors for CAD that usu-
ally exist in patients with obesity. Previous works (Canto et al., 2011; Mamudu et al., 2016)
showed that diabetes, hypertension, hypercholesterolemia, etc., are related to CAD patients,
and these diseases are present in our clusters as well. It is important to note that the sub-
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clusters EC3.1, EC3.2, and EC1.2 include patients a high percentage of whom have three or
more comorbidities. These clusters have a high percentage of patients (over 50%) with at least
two of the mentioned risk factors. This reinforces the theory that the relationship between obe-
sity and CAD is mainly due to the coexistence of many acting morbidities as risk factors for
cardiovascular events.
This study also allows us to see how a pathology behaves in the different clusters. With respect
to CHF and obese patients, (Ahmad et al., 2014) found 4 clusters with phenotypes related
to these diseases. Some important comorbidities they identiﬁed are hypertension, diabetes,
hyperlipidemia, etc. Our clusters (EC2.1, EC2.3, EC3.1) show the presence of the same co-
morbidities as well.
In EC2.3, no patient has diabetes, CHF, HCL, OSA, and a low percentage have CAD and
other diseases. This cluster give us an idea of the multifactorial and multimorbid character
generally associated with obesity. We can say this the healthiest group with the lowest mortality
risk diseases. In medicine, the term “metabolically healthy obese” is used to refer to obese
patients who do not have cardio-metabolic abnormalities associated with adipocytes. Studies
have shown that these patients have an increased risk of mortality compared to normal weight
and metabolically healthy individuals (Kramer et al., 2013). As well, the patients in that cluster
could have lived with a risk factor for a short time period (e.g., few overweight years); they
could also be patients with low BMI. One hypothesis that could be further explored is that
this group seems to contain patients who have been suffering from obesity for a few years or
whose BMI is not too high (overweight or low-grade obesity). The present study does not have
sufﬁcient data to test such a hypothesis.
Another case to analyze is depression. There are diverse opinions respecting the association
of obesity with depression. For example, (Dixon et al., 2003) suggests that depression is as-
sociated with severe obesity, especially among young women that have a poor body image. A
prospective study by (Roberts et al., 2003) indicates that obesity increases the risk of depres-
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sion, but that the inverse is not true, that is, depression does not appear to increase the risk of
gaining weight.
On the other hand, a meta-analysis of 15 prospective observational studies published in 2010
similarly shows that the risk of developing depression among obese patients and among de-
pressed patients is the same; in other words, having either one of these pathologies predisposes
a patient to the other (Luppino et al., 2010).
This may account for 20% (83 patients in the annotated data) of the 412 patients considered in
the present work having depression. In cluster EC1.1, all the patients have depression, while
in EC2.1, EC2.2, EC2.4, and EC3.2, only a moderate percentage of them presents this disease
Asthma is present among a moderate percentage of patients in EC2.1, EC2.2. The relation-
ship between depression and asthma was addressed in a meta-analysis of 8 prospective studies
published by (Gao et al., 2015). This meta-analysis establishes that the risk of developing
asthma increases by 43% among patients who have depression as compared to those who do
not, although asthma does not appear to increase the risk of depression.
3.5 Conclusion and Future Work
Considering 14 obesity comorbidities, clustering analysis at 2 levels was applied. The ﬁrst
level provides a general idea of the prevalent diseases afﬂicting obese patients, as well as the
type of comorbidity (HC and MC) they have. At the second level, groups of patients were
identiﬁed, with more details provided about their comorbidities. Most of the clusters present a
high comorbidity with common diseases mentioned by experts in the literature. Furthermore,
despite the differences in the weights assigned to diseases in the second level, the extracted and
annotated data present some equivalence in the clusters found in both experiments. This shows
that the automatic extraction of medical entities and cluster analysis allow to discover groups
of patients with similar characteristics. These clusters help doctors to gain insights into the
variety of patient phenotyping characterizing a disease such as obesity. The present work has
some limitations that should be covered in future studies. For example, 14 obesity comorbidi-
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ties based on the Obesity Challenge promoted by i2b2 were used, but other diseases present
in the discharge summaries could be considered. Moreover, this work did not distinguish be-
tween diabetes types, as mentioned above; knowing which patients have type 2 DM can help
physicians conﬁrm the relationship between obesity and this disease.
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Abstract
Background: Clinical notes constitute a rich source of medical entities that could be useful in
identifying graphs of patients with similar characteristics. Network-based approaches permit
to visualize associations between medical entities and to infer medical knowledge. This paper
aims to apply such an approach to identify the graphs of obese patients as well as relationships
between diseases and treatments extracted from discharge summaries.
Methods: Two experiments were designed. In the ﬁrst experiment, a 412-node graph rep-
resenting patients was constructed to identify patient groups. Graphs were obtained with the
modularity function. In the second, some bipartite graphs were constructed to identify diseases-
treatments relationships from patient graphs.
Results: The results were congruent in both experiments. Patient graphs corresponding to
obese patients with diseases derived from a metabolic problem were identiﬁed; some had in-
fectious diseases, while others had diseases derived from a mechanical problem. Furthermore,
groups of diseases and treatments related to obesity could be observed.
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Conclusions: This work identiﬁed obesity-patient graphs and relationships between diseases
and treatments based on a network approach, which took into account information extracted
from clinical notes.
Keywords: Electronic medical records, network, graph, obesity.
4.1 Introduction
Obesity and overweight are abnormal or excessive fat accumulation that negatively affect
health (World Health Organization, 2019). These health problems are becoming an epidemic
affecting adults and children. Obesity is accompanied by comorbidities such as: hyperten-
sion, coronary heart disease, stroke, renal diseases, diabetes, gallbladder disease, respiratory
problems, sleep apnea, asthma, osteoarthritis, and cancer (Aneja et al., 2004; Guh et al., 2009;
Apovian, 2016)
Patient information from Electronic Medical Records (EMR) constitutes an important source of
information to analyze health problems such as obesity and overweight. Structured information
(e.g. International Classiﬁcation of Diseases [ICD] codes) from EMR often do not reﬂect
the diagnosis of a population (Shivade et al., 2014; Pantalone et al., 2017), but unstructured
information like clinical notes save a more complete proﬁle of patients’ health. Clinical notes
are a rich source of medical entities (diseases, treatments, drugs) that help classify diseases,
predict patients’ health, and have a better understanding of diseases, treatments, and so on
(Lyalina et al., 2013; Shivade et al., 2014; Zhang et al., 2014; Sutherland et al., 2012).
Obesity is a heterogeneous disease that deserves to be analyzed considering all the possible
comorbidities and health problems that a clinical note can show.
A network-based approach has been used to visualize associations between medical entities and
infer medical knowledge (Bauer-Mehren et al., 2013; Zhao et al., 2017). For instance, (Lyalina
et al., 2013) visualize phenotype-phenotype association extracted from medical records related
to three neuropsychiatric disorders. Also, (Roque et al., 2011) visualize clusters of patients
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constructed with International Classiﬁcation of Diseases (ICD)10 codes extracted from medi-
cal records of psychiatric patients. Furthermore, (Gangopadhyay et al., 2016) applied graphs
to identify the main patterns related to anemia within clinical notes. In their work, (Khan
et al., 2018) extracted ICD codes from type-2 diabetes patients’ admission history and cre-
ated networks to identify the comorbidities and conditions related to the disease. Similarly,
using ICD codes, (Kalgotra et al., 2017) identiﬁed comorbidities classiﬁed by gender. Also,
(Merrill et al., 2015) used a network approach based on information pertaining to inpatient and
outpatient clinical services to identify care patterns for congestive heart failure.
Bipartite graph is other concept used to analyze relations between biomedical information.
(Goh et al., 2007) used a bipartite graph to relate disorders and disease genes. The list of dis-
orders, genes and associations between them was obtained from Online Mendelian Inheritance
in Man (OMIM). Also, (Bhavnani et al., 2011) used bipartite graphs to represent asthma pa-
tients and cytokines relationships. They worked with the data from a secondary analysis of
cytokine proﬁles collected in a consortium-wide study (Brasier et al., 2008). Moreover, (Zhou
et al., 2014) based on biomedical literature constructed a symptom-disease network to identify
relationships between clinical manifestations and molecular interaction.
Therefore, different diseases have been analyzed with a network approach, but to date has not
been a work that uses this approach to explore obesity disease based on clinical notes. The
work of (Gangopadhyay et al., 2016) is close to our idea of using a network approach with
information from clinical notes, but whereas they identiﬁed patterns of diseases, our work is
focused on identifying groups of patients with similar characteristics. Also, to our knowledge,
there has not been work that uses bipartite graphs in order to analyze relationships between
diseases and the treatment used in speciﬁc group of patients.
Based on the above observations, and given the importance of clinical notes as a source of
information, two goals were deﬁned for this work. First, we will identify graphs or groups
of patients with similar characteristics based on diseases extracted from discharge summaries.
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Secondly, we will examine the association between diseases and treatments considering the
graphs identiﬁed earlier.
4.2 Methodology
4.2.1 Automatic Extraction and Aggregation of Medical Entities
From the i2b2 Obesity dataset (Uzuner, 2009), 412 discharge summaries were used, much
like in our previous work (Reátegui & Ratté, 2018b). Also, in that previous work, we showed
that MetaMap is a good strategy to extract medical entities, therefore this tool was used to
automatically extract medical entities from the summaries. The concepts extracted correspond
to the following Uniﬁed Medical Language System (UMLS) (National Library of Medicine
(US), 2009) semantic types: disease or syndrome (dsyn), mental or behavioral dysfunction
(mobd), neoplastic process (neop), therapeutic or preventive procedure (topp), pharmacologic
substance (phsu), antibiotic (antb), and clinical drugs (clnd). For ease of writing, dsyn, modb
and neop are going to be jointly called diseases hereafter, while topp, phsu, antb, clnd will
collectively be called treatments.
An aggregation was also performed to reduce and group some diseases and treatments. Fol-
lowing that, we decided to eliminate the features that were present in less than 10 patients;
that led to 343 features corresponding to 86 diseases and 257 treatments. The extraction and
aggregation process were based on our previous works (Reátegui & Ratté, 2018b,a).
In the ﬁrst experiment, we worked with the diseases as features, and in the second, we consid-
ered the patients suffering from speciﬁc diseases and some relevant treatments.
4.2.2 Graph Representation
Graphs or networks represent interactions between nodes or elements (Kalgotra et al., 2017).
A node represents any discrete entity (e.g., an individual or an event), and an edge indicates a
relationship between nodes (Merrill et al., 2015). The algorithm of Blonde et al., implemented
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in Gephi, was used to calculate modularity partitions (Blondel et al., 2008). The modularity
with a positive value indicates the possible presence of a community structure (Blondel et al.,
2008; Newman, 2006); therefore, a positive value will help to evaluate the partitions found.
Furthermore, bipartite graphs were constructed to identify relationships between diseases and
treatments. In a bipartite network, nodes are divided into two non-overlapping sets, and the
edges only join two nodes in different sets (Chang & Tang, 2014; Guimera et al., 2007). In our
cases, one set represents diseases and the other, treatments.
The two experiments were constructed as follows:
- First experiment: Considering the information of 412 patients and 86 diseases, we con-
structed an adjacency matrix with 412 nodes that represent the patients. This process was
used in our previous work (Reátegui & Ratté, 2018a). The undirected edges represent the
co-occurrence of diseases between two patients. Using Gephi and the modularity function
some sub-graphs were obtained. These sub-graphs are groups of patients with similar dis-
eases. Hence, we named these graphs “patient graphs”. In this experiment, the modularity
function was used at two levels. At the ﬁrst level, the algorithm was applied over the graphs
constructed from the adjacency matrix (412 nodes), and at the second, the same algorithm
was used in each sub-graph obtained at the ﬁrst level.
- Second experiment: To analyze and visualize the treatment for some groups of patients
(specially the sub-graphs obtained from the ﬁrst experiment), we constructed a bipartite
graph to relate the diseases and treatments in each group. Before obtaining the bipartite
graphs, some previous steps were taken: (1) An adjacency matrix was created from a matrix
where the rows represented the patients to analyze, and the columns represented the features
extracted. (2) The diseases and the relevant treatment to analyze were ﬁltered. (3) Using
Gephi and the Event Graph Layout plugin, the bipartite graph was created. The undirected
edges represent relationships between diseases and treatments. We named these graphs
“treatment graphs”.
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4.3 Results
4.3.1 First Experiment: Patient Graphs
The graphs or communities of Figure 4.1 were obtained. At the ﬁrst level, 3 graphs (SG0,
SG1, SG2) were obtained. The percentage of patients suffering from some of the 30 relevant
diseases in each graph are shown in Table 4.1. At the second level, eight new graphs were
found. Table 4.2 shows details of the 30 most relevant diseases in each graph.
Patient Graphs
412 nodes (patients)
Sub-graphs from SG2
Sub-graphs from SG0
Sub-graphs from SG1 
SG2.0
(72 nodes)
SG2.1
(36 nodes)
SG0.0
(44 nodes)
SG1.1
(56 nodes)
SG1.2
(44 nodes)
SGS1.0
(51 nodes)
SG1
(151 nodes)
SG0
(95 nodes)
SG2
(166 nodes)
SG2.2
(58 nodes)
SGS0.1
(51 nodes)
Figure 4.1 Graphs obtained in the ﬁrst experiment. An the ﬁrst
level, 3 sub-graphs were obtained (SG0, SG1, SG2). At the
second level, 8 sub-graphs were obtained: SG0.0 and SG0.1 from
SG0; SG1.0, SG1.1 and SG1.2 from SG1; SG2.0, SG2.1 and
SG2.2 from SG2.
4.3.2 SecondExperiment: Treatment Graphs
Table 4.3 shows details of the 30 relevant treatments in each bipartite graph analyzed in this
experiment. Also, Figure 4.2 presents the bipartite graphs.
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Table 4.1 Details of the 30 prevalent diseases from
patient graphs in the ﬁrst level
Diseases extracted automatically Sub-graphs
Num Diseases Total % SG0 SG1 SG2
1 Hypertensive disease 323 78 69 81 81
2 Hyperglycemia 250 61 81 66 43
3 Congestive heart failure 158 38 45 38 35
4 Hyperlipidemia 155 38 34 54 25
5 Sleep apnea syndrome 138 33 8 3 75
6 Heart diseases 129 31 16 68 7
7 Morbid obesity 102 25 15 8 46
8 Communicable disease 95 23 55 9 17
9 Cardiomyopathy 88 21 7 47 6
10 Deep vein thrombosis 80 19 14 12 30
11 Asthma 79 19 8 10 34
12 Fibrillation 78 19 25 22 13
13 Chronic kidney disease 78 19 38 17 10
14 Gastroesophageal reﬂux disease 78 19 6 15 30
15 Depressive disorder 74 18 14 11 27
16 Left ventricular hypertrophy 73 18 22 18 15
17 Anemia 70 17 30 10 16
18 Degenerative polyarthritis 70 17 13 11 25
19 Erythema 70 17 27 12 16
20 Chronic obstructive airway disease 68 17 11 13 22
21 Urinary tract infection 67 16 38 7 12
22 Lung diseases 59 14 14 9 19
23 Cancer 59 14 17 15 12
24 Gout 58 14 15 8 19
25 Vascular disease 57 14 14 21 8
26 Kidney diseases 53 13 30 11 4
27 Renal insufﬁciency 49 12 22 7 11
28 Anxiety 47 11 16 7 13
29 Pneumonia 45 11 17 11 8
30 Cerebrovascular accident 44 11 11 15 6
Patients per sub-graph 95 151 166
The results of the sub-graphs are represented in percentages according to the number of patients in each group.
Bold numbers represent diseases present in more than 30% of the population in each sub-graph.
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Table 4.2 Details of the 30 prevalent diseases from the
patient graphs in the second level
Diseases Sub-graphs from SG0 Sub-graphs from SG1 Sub-graphs from SG2
SG0.0 SG0.1 SG1.0 SG1.1 SG1.2 SG2.0 SG2.1 SG2.2
Hypertensive disease 84 57 80 91 70 78 72 30
Hyperglycemia 75 88 65 73 59 36 8 25
Congestive heart failure 73 22 98 7 7 10 50 19
Hyperlipidemia 45 25 53 64 41 13 19 15
Sleep apnea syndrome 9 8 4 2 5 76 56 29
Heart diseases 18 14 63 64 77 7 3 3
Morbid obesity 18 12 10 2 14 74 58 1
Communicable disease 34 75 6 9 14 21 8 6
Cardiomyopathy 7 8 55 0 98 6 3 3
Deep vein thrombosis 11 16 24 4 9 39 19 8
Asthma 7 10 8 11 11 33 22 14
Fibrillation 30 22 47 11 7 11 28 2
Chronic kidney disease 48 29 33 5 14 13 6 3
Gastroesophageal reﬂux disease 11 2 14 18 14 10 42 16
Depressive disorder 11 16 10 7 16 24 22 12
Left ventricular hypertrophy 41 6 20 21 11 11 8 8
Anemia 45 18 10 11 9 10 19 7
Degenerative polyarthritis 16 10 10 14 9 6 92 2
Erythema 2 49 6 14 16 28 8 2
Chronic obstructive airway disease 9 14 8 13 20 14 17 12
Urinary tract infection 57 22 4 7 11 17 8 3
Lung diseases 9 18 12 2 16 21 25 5
Cancer 11 22 18 11 18 19 8 2
Gout 23 8 10 5 9 7 19 12
Vascular disease 11 16 25 16 20 11 0 3
Kidney diseases 45 18 20 5 9 4 0 2
Renal insufﬁciency 32 14 14 4 2 8 3 6
Anxiety 18 14 8 4 9 8 17 6
Pneumonia 2 29 10 7 16 4 3 5
Cerebrovascular accident 16 8 22 9 16 6 6 2
Patients per sub-graph 44 51 51 56 44 72 36 58
The results of the sub-graphs are represented in percentages according to the number of patients in each group.
Bold numbers represent diseases present in more than 29% of the population in each sub-graph.
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4.4 Discussion
Using a network-based approach, we found patient groups and some relationships between
diseases and treatments conﬁrming the comorbidities affecting the obese patients.
Next, we will present the analysis of our experiments.
4.4.1 First Experiment: Patient Graphs
SG0 has 95 patients. This graph is composed mostly of non-morbidly obese people who have
developed hypertension (69%) as a direct complication. The main characteristics of this graph
is that they are obese with metabolic problems such as hyperglycemia (81%). Possibly, they
are people with insulin resistance that is manifested before the onset of hyperglycemia (Beck-
Nielsen & Groop, 1994). Also, several studies show obesity as a metabolic risk for type 2
diabetes, observing that over 80% of such cases can be attributed to obesity (Mokdad et al.,
2003).
SG0 has a signiﬁcant percentage of patients with kidney pathologies. As an example, SG0.0
has 48% of the patients with chronic kidney diseases, 45% with kidney diseases, and 32%
with renal diseases. The Hypertension Detection and Follow-Up Program and the Multiphasic
Health Testing Services Program suggest that obesity can be an independent risk factor for
developing chronic renal failure, but on the other hand, the Framingham Offspring Study states
that obesity is not an independent risk factor for developing CRF, and that it must be associated
with diseases such as diabetes or hypertension, tobacco use, and so on (Kramer et al., 2005;
Foster et al., 2008).
Hyperglycemia is directly related with obesity and other pathologies of infectious origin (as-
sociated with social relationships and dangerous, risky or disordered lifestyles). This may
explain the high frequency of signs such as erythema among 49% of the patients in SG0.1, and
other less obvious signs such as anemia, present in 45% in SG0.0. Obese patients, indepen-
dently of the coexistence of other pathologies, are more susceptible to developing infectious
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processes (Falagas & Kompoti, 2006). In obesity conditions, physio-pathological phenom-
ena affect the immunological processes. This impacts the stability of the organic protection
mechanisms against infectious aggressions. The relationship between obesity and an increased
frequency of infectious processes is clearly described in the medical literature. This is not a
cause-consequence relationship, but rather, a factor that modiﬁes the capacity of individuals
with body weight disorders to respond to infection attacks.
SG1 has 151 patients. This graph is also composed of non-morbidly obese people. 81% of
them have hypertension; 66%, hyperglycemia, and 54%, hyperlipidemia. These patients have
developed cardiovascular complications. For example, 98% of the patients in SG1.0 have
congestive heart failure, 63% have heart disease and 55% have cardiomyopathy. Also, these
patients have had cerebrovascular accidents.
A “metabolic” mechanism is a common factor of the diseases in SG1, which can be derived
from overweight and obesity. The association of deleterious changes in the lipid metabolism of
obese patients is manifested through high concentrations of cholesterol, low-density lipopro-
tein cholesterol (LDL), very low-density lipoprotein cholesterol (VLDL), triglycerides and a
reduction of high-density lipoprotein cholesterol (HDL). The reduction of HDL has been ob-
served to present a higher relative risk of developing coronary heart disease (The Emerging
Risk Factors, 2011).
Several studies show a linear relationship between obesity and the incidence of coronary heart
disease, in addition to a gradual positive relationship between the body mass index (BMI) and
risk factors for coronary heart disease, such as dyslipidemia, hypertension and diabetes (Poirier
et al., 2006).
SG1 describes the association between obesity and metabolic diseases, which in this case,
is explained as a direct impact of increased body weight on metabolic phenomena. Patients
in SG1 may have the worst prognosis because they present a high percentage of heart and
cerebrovascular disease (Daniels, 2012).
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SG2 has 166 patients. This graph comprised a signiﬁcant percentage of patients with morbid
obesity (46%), obstructive sleep apnea (75%), gastroesophageal reﬂux disease (30%), asthma
(34%), and poly-arthritis (25%). Looking for a common pathophysiological denominator, SG2
could be explained from a "mechanical" point of view. The mechanical effect of increased body
mass (overweight and obese) directly affects the development of disorders such as obstructive
sleep apnea syndrome (OSAS) and gastrointestinal reﬂux (GERD).
Obesity is a risk factor for gastrointestinal (GI) disease, which includes GERD, erosive esophagi-
tis, esophageal adenocarcinoma and gastric cancer (body fatness). For example, SG2.1 has
42% of the patients with GERD. A “mechanical” process (ampliﬁed intragastric pressure), in-
creases the risk of GERD (Cook et al., 2008). GERD is in the differential diagnosis of OSAS
because it can present similar symptoms due to the irritation of the upper airway by the arrival
of stomach acids. As an aside, GERD would seem to beneﬁt from nocturnal oxygen therapy
(OSAS treatment). In addition to the association by similarity of symptoms, an independent
association between both pathologies has been found (Gilani et al., 2016). We can see this
in SG2.1, where OSA is present in 56% of the patients and GERD in 42%. Also, GERD is
precursor to the appearance of asthma and other related problems, such as chronic obstructive
pulmonary disease (COPD) (Cook et al., 2008; Peppard et al., 2000).
OSAS is strongly associated with the existence of obesity (e.g., SG2.0, SG2.1). Obesity acts
as a more powerful risk factor in the development of OSAS, and its relative risk is higher when
the BMI increases (Peppard et al., 2013). OSAS is a clear risk factor for cardiovascular events
(e.g., SG2.1), although it is not entirely clear whether it is due to its high association with
obesity or other coexisting factors (Wolf et al., 2007).
Moreover, asthma is present in these patients (e.g., SG2.0). Several studies have identiﬁed a
higher prevalence of asthma among obese individuals than in those with normal BMI (Cook
et al., 2008). Asthma and OSA usually coexist in patients by having shared desiccating factors
such as nasal irritation and obesity (Devouassoux et al., 2007). In SG2.0, 76% of the patients
have OSA and 33% have asthma.
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Another signiﬁcant problem present in SG2 is deep vein thrombosis, with 39% of the patients
in SG2.0 having this disease. In this case, its development would be explained by mechanical
effects, derived from overweight, which affect the venous return (Delluc et al., 2009).
Depression is another pathology representative of this graph (e.g., SG2.0). It has been observed
that depression is more associated with severe obesity (Dixon et al., 2003).
Degenerative poly-arthritis or osteoarthritis (OA) is a disease present in SG2.1, with a big per-
centage of patients (92%) having it. Osteoarthritis is a disease characterized by the progressive
degeneration of articular joints. Obesity and overweight are primary risk factors for OA, and
mechanical factors increase the risk its progression (Francisco et al., 2018). Because of excess
loads on any weight-bearing joint, the surface of the cartilage suffers tear and wear (Berenbaum
et al., 2013).
Finally, it should be stated that hypertension is a pathology with high percentages in all sub-
graphs. Hypertension cannot be classiﬁed in a speciﬁc group due to the strong relationship
between obesity and hypertension and the pathophysiological mechanisms with which this
disease occurs. For this reason, hypertension in patients with high BMI is treated through
weight loss (Aneja et al., 2004; Daniels, 2012).
4.4.2 Second Experiment: Treatments Graphs
Is should be recalled that our dataset is characterized by patients suffering from obesity, with a
high presence of hypertension and hyperglycemia. Therefore, the “treatments graphs”, certain
drugs such as aspirin, angiotensin-converting enzyme inhibitors, insulin and laxative drugs are
present, along with a low-fat diet.
In addition, as we can see in the graphs obtained in the ﬁrst experiment, obese patients have
certain comorbidities, and as a result, the treatment for a speciﬁc disease is accompanied with
treatments for other diseases. This notwithstanding, and depending on the group of patients,
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some treatments appear with more frequency for speciﬁc diseases present in the graph. Next,
we will analyze some cases.
Hyperglycemia diseases: This bipartite graph was created considering the information of
all patients (250) that have hyperglycemia. The graph shows treatments such as insulin and
glucose. Treatment with insulin is used in different types of diabetes mellitus. All patients
with type 1 diabetes need insulin, while for those with type-2 diabetes, insulin is only required
when hyperglycemia persists against oral agents, or when the patient has a severe metabolic
disturbance such as plasma glucose greater than 250 mg/dl or HbA1C > 9.5. Among the
complications of the use of insulin is an increase in weight and the hypoglycemia. The presence
of hypoglycemia justiﬁes the use of glucose in this group of patients. Hypoglycemia is found
to be more prevalent in type 1 diabetics than in type 2 (UK Hypoglycaemia Study Group,
2007). This bipartite graph also comprises a variety of treatments for infection, lipid reduction,
anticoagulants, reﬂux treatments, and so on, which shows the diversity of diseases present in
the patients.
Renal diseases: This bipartite graph was created taking into account the patients (126) having
at least one of these diseases: chronic kidney disease, kidney disease, and renal insufﬁciency.
Dialysis, Toprol, furosemide, and diurese are the treatments shown on this graph. As well, the
graph also presents treatments for infection, anemia, hypertension, and diabetes. As we can
see in SG0.0, these diseases appear together with renal diseases.
OSA diseases: This bipartite graph was created considering the information of all patients who
have OSA. 138 patients suffer from this disease. The graph shows treatments for OSA, such
as continuous positive airway pressure, oxygen, and air. It also shows a variety of treatments
for diseases such as gastroesophageal reﬂux disease, asthma, and deep vein thrombosis. These
diseases are pathologies with physio-pathological phenomena, and with a mechanical function
resulting from a high body weight. In this sense, the evidence is clear that obesity triggers
alterations in the function of multiple organs and systems. Therefore, it is at the root of several
diseases which further complicate the health of obese patients.
72
The pharmacological therapy used in this group strengthens the hypothesis that this group
is represented by obese patients with mechanical respiratory and gastrointestinal problems.
Hence, in this graph, we have drugs such as bronchodilators, antitussives, and antihistamines,
which are speciﬁcally for pathologies such as asthma. We also have drugs such as proton-
pumps inhibitors and antacids, which are used to treat reﬂux.
Asthma and deep vein thrombosis: SG2.0, with 72 patients, is an OSA graph with a moderate
percentage of patients with asthma and deep vein thrombosis. The bipartite graph for asthma in
SG2.0 shows albuterol, advair diskus, and antihistamine drugs that are speciﬁcally for diseases
such as asthma. For deep vein thrombosis, the bipartite graph shows heparin and Coumadin,
which are drug used to treat this disease.
Degenerative poly-arthritis and GERD: SG2.1, with 36 patients, is also an OSA graph with a
high percentage of patients with degenerative poly-arthritis (92%). The bipartite graph that rep-
resents the relationship between degenerative poly-arthritis and treatments shows oxycodone,
Tylenol, acetaminophen and a nonsteroidal anti-inﬂammatory agent, all of which are used to
relieve pain. SG2.1 has 42% of patients with gastroesophageal reﬂux diseases. Therefore,
the bipartite graph that represents the relationship between GERD and the treatments shows
inhibitors of proton pumps, Nexium, and antacids, which are used to treat reﬂux.
Cardiomyopathy: This bipartite graph was created considering all the patients (88) with
cardiomyopathy. Some of the treatments related to this disease shown in the graph include:
furosemide, Toprol, heparin, Coumadin, nitroglycerin, atenolol and calcium channel blockers.
SG1.0 and SG1.2. are examples of graphs with high percentages of patients with this disease.
Heart disease: SG1.1 does not have patients with cardiomyopathy, but it has 64% of patients
with heart disease. We created a bipartite graph for this disease, taking into account the 56
patients in SG1.1. The bipartite graph shows drugs such as statins and aspirin, used as treat-
ment and to prevent cardiac complications. Also, we can see medications for cardiovascular
complications such as beta blockers and antiarrhythmic, as well as procedures such as cardiac
bypass.
73
The SG1 graph has a high percentage of patients with hyperlipidemia and hyperglycemia,
which is why the bipartite graph for cardiomyopathy and heart disease also shows treatments
that control these diseases with a metabolic origin.
4.5 Conclusion
Based on of 86 diseases and 257 treatments extracted from discharge summaries of 412 obese
patients, and using a network-based approach, we could analyze and visualize information
related with obesity diseases. We identify three large groups or graphs that could contribute to
a new classiﬁcation of obesity disease. The classiﬁcation is as follows: 1. Obese patients with
infections problems (SG0), 2. Obese patients with metabolic problems (SG1), and 3. Obese
patients with a mechanical problem (SG2). Also, it was possible to visualize associations
between diseases and treatments.
This work has some limitations. We did not consider information such as BMI, gender, race
or other features, which could help reﬁne the sub-graph. Also, adding more information to our
extracted features could help us identify possible tailored treatments for each graph found in
the ﬁrst experiment. In biomedicine, current works focus on stratiﬁed medicine, with the aim
of ﬁnding the best therapy for a patient graph, and the future will see personalized medicine
aimed at ensuring decisions, practices and therapies tailored to individual patients (Holzinger,
2016).
In future work, we would like to experiment with the introduction of new features as afore-
mentioned. Also, the time when diseases and treatments appear could offer insights regarding
the progress of a patient’s health.

CHAPTER 5
GENERAL DISCUSSION
This thesis addresses two main tasks: medical entity extraction and medical entity analysis.
Regarding the medical entity extraction or recognition task, MetaMap and cTAKES were used
to extract 14 obesity comorbidities from discharge summaries. A comparison of both tools
was made, and showed cTAKES slightly outperforming MetaMap; however, this could change
since both tools constantly release new versions and conﬁguration options. Such changes could
lead to new results, even in the same datasets.
It is important to consider that health professionals usually write an entity name in different
ways (e.g., depressive disorder, mental depression) or they may describe a medical procedure
instead of a disease (e.g., cholecystectomy instead of cholecystolithiasis). The different ways
of writing or describing medical entities also means that terminology such as UMLS could
recognize the same entity with different codes belonging to the same or different semantic
types. Therefore, an aggregation process considering semantic types and relationships deﬁned
in the UMLS could improve the results.
Moreover, methods such as rules-based, machine learning and deep learning have performed
well in medical entity extraction, but they require experts, annotated datasets, and a consider-
able amount of information. Therefore, the methods are time consuming and expensive, which
then makes using MetaMap and cTAKES a good medical entity extraction strategy.
Figure 5.1 presents a general view of the medical entity extraction and aggregation process.
The steps are detailed below:
- From discharge summaries, extract diseases (medical entities) using Metamap or cTAKES.
- Create a matrix where a row represents a patient, and the columns are the diseases patient
has.
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- Based on UMLS (terminology, thesaurus) and the entities extracted, identify semantic types
and concepts relationships.
- Aggregate de diseases or medical entity considering the previous step.
Discharge
Summaries 
MetaMap/
cTAKES
Entities 
Extracted
???????
?
???????
?
???????
?
???????
?
??
??
??
?
????
Entities 
Aggregated 
????????
????????????????????
????????
????????????????????
??
??
??
?
????
Aggregation 
process
Semantic 
types
Concepts 
relationship
Figure 5.1 Process to extract and aggregate medical entities
Two approaches to patients cluster analysis were also described. In the ﬁrst approach, a cluster
analysis with a sparse K-mean algorithm was applied at two levels. This approach helps clearly
identify the main features of each cluster. Works such as (Sutherland et al., 2012; Laing et al.,
2015; LaGrotte et al., 2016) consider two or three comorbidities in identifying obesity clusters.
In contrast, this thesis analyzed 14 obesity comorbidities. The i2b2 obesity dataset contains 15
comorbidities annotated by experts; 14 of them (hyperglycemia was excluded) were used as
features in the cluster analysis. Hence, to the best of our knowledge, this is the ﬁrst attempt
at identifying clusters of patients based on comorbidities as features. Moreover, the 14 comor-
bidities were automatically extracted from discharge summaries, while other studies obtain
features mainly from patient measurements or through interviews or questionnaires.
Figure 5.2 shows the patients clusters analysis process using sparse K-means. The steps are
detailed below:
- From discharge summaries, extract medical entities using a NER tool such as cTAKES or
Metamap.
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Discharge 
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??
??
??
?
?
?
Diseases extracted 
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Cluster of patients
Extraction task Sparse K-means
First Level Second 
Level
Figure 5.2 Patients cluster analysis process with sparse K-means
- Create a matrix where a row represents a patient, and the columns are the medical entities
extracted and aggregated.
- Use a two-level sparse K-means algorithm. At the ﬁrst level, the algorithm is applied to the
number of patients to be analyzed. At the second, the algorithm is applied to each cluster
identiﬁed in the ﬁrst level.
After analyzing the 14 comorbidities mentioned above, and with the aim of exploring more
information from discharge summaries, 86 diseases and 257 treatments were extracted. A
network-based approach was considered to visualize and explore the medical entities. The
modularity function was applied at two levels to identify patient communities or clusters. The
results show three main clusters of patients representing obese patients with infection prob-
lems, obese patients with diseases derived from a mechanical problem, and obese patients with
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diseases derived from a metabolic problem. The clusters found provide new insights into a new
obese patient classiﬁcation based on the diseases afﬂicting patients.
In addition, the results show that information inside unstructured medical notes save more
details about a patient’s health. This information enables a better understanding of a disease.
To date, the works of (Roque et al., 2011; Gangopadhyay et al., 2016) come closest to our idea
of identifying patient clusters and disease-treatment relationships using unstructured data from
EHR with a network-based approach. On the one hand, (Roque et al., 2011), worked with
information on patients with mental problems and used a similarity cosine to identify patients
clusters; for this thesis, I worked with obese patients and a modularity function to identify
patient clusters or communities. Unlike the work of (Gangopadhyay et al., 2016) which used a
modularity function to extract patterns of a disease from EHR, this thesis worked with patient
clusters.
The network approach plays an important role in information visualization. Therefore, after
identifying patient clusters and disease-treatment relationships, some clusters were visualized
and analyzed. Although most of the relationships were from a speciﬁc disease or group of
related diseases (e.g., renal insufﬁciency, chronic kidney disease, kidney diseases) to some
treatments, the bipartite graphs shows treatments related with other diseases. This conﬁrms
that some comorbidities affect obese patients.
Figure 5.3 shows the patient clusters and disease-treatment relationship identiﬁcation process
using a network-based approach. The steps are detailed below:
- From discharge summaries, extract medical entities using a NER tool such as cTAKES or
Metamap.
- Create a matrix where a row represents a patient, and the columns are the medical entities
extracted and aggregated.
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- Use a two-level modularity function. At the ﬁrst level, the function is applied to the number
of patients to be analyzed. At the second level, the function is applied to each cluster
identiﬁed in the ﬁrst level.
- Based on the patients treatments extracted and the clusters found in the former step, use
bipartite graphs to identiﬁed diseases-treatments relationships.
Discharge 
summaries
?? ?? ? ?? ?? ?
??
??
??
?
?
?
Diseases and 
treatments extracted
Patient Graphs
Disease-treatments 
relationships
Extraction task
Figure 5.3 Network-based approach to medical entities
exploration
In general, this thesis addresses a new option for characterizing obese patients based on co-
morbidities and other diseases suffered by such patients. Furthermore, this work describes a
new methodology for analyzing medical information from clinical notes that could be applied
to explore new diseases. The main steps (see Figure 5.4) developed are:
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Figure 5.4 General methodology to identiﬁed clusters of patients
at two levels
- Automatically extract medical entities from clinical notes. Today, we have tools that could
be used for this task. A combination of some tools such as MetaMap and cTAKES could
constitute a good strategy.
- Aggregate medical entities considering different semantic types and relationships. Special-
ized vocabularies and standards such as UMLS and SNOMED-CT feature a medical entity
classiﬁcation that enables an aggregation process.
- Create a matrix where a row represents a patient, and the columns are the medical entities
extracted and aggregated.
- Identify patient clusters, considering cluster analysis or network approach. Considerate
a two-level analysis. At the ﬁrst level, where the method is applied to the entire data (pa-
tients), the clusters show characteristics that provide a general understanding of the diseases
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affecting patients in that groups. At the second level, where the method is applied to clusters
from the ﬁrst level, the results show more detailed information about the patient groups.

CONCLUSION AND RECOMMENDATIONS
The main objective of this thesis was to analyze clinical notes in order to extract hidden data
and information related to obese patients. This objective was achieved through three main
contributions. First, we extracted medical entities from existing tools. Second, clusters of
patients were identiﬁed using a cluster analysis based on 14 obesity comorbidities. Third, a
network-based approach was used to visualize and explore relationships between diseases and
relationships between diseases and treatments.
14 obesity comorbidities were extracted with MetaMap and cTAKES tools. This extraction
allowed a comparison of these tools and some remarks about the medical entity aggregation
process. In the dataset selected, the result showed that cTAKES slightly outperforms MetaMap.
The bottom line is that either of these tools could be selected for the extraction task. However,
the aggregation process plays an important role in improving results, and terminologies such
as UMLS could be used for this process.
Two-level sparse k-means algorithms were used to ﬁnd clusters of patients based on 14 obesity
comorbidities. At the ﬁrst level, three types of clusters (low, medium and high comorbidity)
were identiﬁed based on the number of comorbidities and the percentage of patients suffering
from them. At the second level, clusters were identiﬁed, with more details provided about their
comorbidities. Using the sparse K-means enables identiﬁcation of features, or in these cases,
comorbidities that are more representative (based on the weights) for each cluster.
To visualize and analyze the association between medical entities extracted from clinical notes,
a network-based approach was applied. Based on 86 diseases, three main obesity clusters were
identiﬁed. Although the process of extracting medical entities did not require the intervention
of experts, physicians have a crucial role in the validation of the clusters and in naming the
clusters: patients with metabolic problems, patients with infections problems, and patients
with a mechanical problem. Furthermore, disease-treatment associations were found in some
84
of the clusters. Compared to the experiment in chapter 3, a network-based approach applied on
clinical note information provides a way to visualize entity relationships and infer new insights
about comorbidities and treatments for speciﬁc diseases.
Through the above-mentioned contributions, this thesis shows that clinical notes provide health
professionals and researchers with new insights about diseases.
Future works
This thesis has some limitations that should be covered in future studies.
A comparison of MetaMap and cTAKES was done, but a combination of both tools could rep-
resent a good strategy for NER in the medical domain. Also, comparisons using other datasets
and new versions of the tools could help discover new insights about the tools themselves and
their conﬁguration options applied to new datasets. Furthermore, the use of other methods like
rule-based approach could be used to compare and validate the result.
A technical aspect to take into account is that, for now, there is no tool or application that can
automatically aggregate extracted entities. UMLS has a list of semantic types and relation that
could be used to automatically aggregate concepts that correspond with the same or different
semantic type.
All experiments in this thesis did not consider the the temporal aspect of the problem, e.g.
when the diseases or treatment appears. For future works, the inclusion of time could help
understand the inﬂuence of a comorbidity or treatment in the progress of a disease. Also,
the inclusion of a different medical entity (e.g., laboratory test), features such as sex, age,
geographical distribution, corporal measurements (e.g., height, weight, BMI), etc., could help
discover new characteristics about patients’ health. Similarly, in this work, an aggregation of
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some diseases was made, but different types of a disease (e.g., types 1 and 2 diabetes) can help
in ﬁnding more details about a disease.
Furthermore, the exploration of new datasets on other diseases or even in other languages
could be considered. Of special interest for future works is a medical dataset in Spanish that
could allow the exploration of medical entity associations and other medical circumstances in
underdeveloped countries. That is a big challenge because most datasets for research are only
available in English.
Moreover, to date, there is not tool that allow the automatically extraction of entities from clin-
ical notes written in Spanish. The scarcity of this type of tools opens the possibility of new
researches and works for the extraction of entities in new languages. The use of dictionaries,
rule-based and machine learning approaches have been explored in the past for this task. Also,
deep learning has been employed in recent years to identify a medical condition or pheno-
type (Gehrmann et al., 2018; Cheng et al., 2016), to represent and predict the patients’ health
(Miotto et al., 2016), etc. Hence, these methods are complementary to our works, and therefore
could be applied in future work.
In this thesis, the opinion of experts were taken into account to validate the result obtained
with the cluster analysis and network approaches, but a comparison with "rule-based systems
created by experts" could be covered in future researches.
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